+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 48283

Chapter 48283 contains a list of PDF Full Texts available from EurekaMag.





Causse, M.; Franco-Alvarez de Luna, F.; García-Mayorgas, A.D.; Rodríguez, F.C.; Casal, M., 2006:
Antimicrobial susceptibility of Enterococcus faecalis isolated from patients in Córdoba (Spain)

Sánchez Merino, J.M.; Guillán Maquieira, C.; Fuster Foz, C.; López Medrano, R.; Jiménez Rodríguez, M.; García Alonso, J., 2004:
Antimicrobial susceptibility of Escherichia coli isolated from bacteriurias in Bierzo health area during 2003

Kiffer, C.; Hsiung, A.; Oplustil, C.; Sampaio, J.; Sakagami, E.; Turner, P.; Mendes, C., 2005:
Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003

Jamie, W.E.; Edwards, R.K.; Duff, P., 2003:
Antimicrobial susceptibility of Gram-negative uropathogens isolated from obstetric patients

Thornsberry, C.; Kirven, L.A., 1974:
Antimicrobial susceptibility of Haemophilus influenzae

Abdulrasheed, A.; Lawal, O.O.; Abioye-Kuteyi, E.A.; Lamikanra, A., 2005:
Antimicrobial susceptibility of Helicobacter pylori isolates of dyspeptic Nigerian patients

Nahar, S.; Mukhopadhyay, A.K.; Khan, R.; Ahmad, M.Mashhud.; Datta, S.; Chattopadhyay, S.; Dhar, S.Chandra.; Sarker, S.Alam.; Engstrand, L.; Berg, D.E.; Nair, G.Balakrish.; Rahman, M., 2004:
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh

Stathi, M.; Flemetakis, A.; Miriagou, V.; Avgerinou, H.; Kyriakis, K.P.; Maniatis, A.N.; Tzelepi, E., 2006:
Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004

Mahamat, A.; Lavigne, J-P.; Bouziges, N.; Daurès, J-P.; Sotto, A., 2006:
Antimicrobial susceptibility of Proteus mirabilis urinary tract isolates from 1999 to 2005 at Nîmes University Hospital

Gomila Sard, B.; Pardo Serrano, F.J.; Moreno Muñoz, R.; Celades Porcar, E.; García del Busto Remón, A., 2006:
Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Castellón, Spain

Guerrero, C.; Cesteros, R.; Miranda, A.; Menasalvas, A.; Blázquez, R.; Segovia, M., 2004:
Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Murcia, Spain

Nasu, Y.; Abe, M.; Ono, N.; Araki, M.; Horimi, T.; Takahashi, I., 2005:
Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years

Nishimura, S.; Tsurumoto, T.; Yonekura, A.; Adachi, K.; Shindo, H., 2006:
Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases

Castanheira, M.; Gales, A.C.; Mendes, R.E.; Jones, R.N.; Sader, H.S., 2004:
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program

Saldías P, F.; Flores S, L.José.; Torres M, C.; García C, P.; Díaz F, A., 2005:
Antimicrobial susceptibility of Streptococcus pneumoniae in pediatric and adult population from Santiago, 1997-2003

Montagnani, F.; Stolzuoli, L.; Zanchi, A.; Cresti, S.; Cellesi, C., 2006:
Antimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: surveillance from 1993 to 2004 in Central Italy

Vera, L.Angel.; Macedo, J.Lessa.Soares.de.; Ciuffo, I.Allen.; Santos, Cção.Guerra.; Santos, Jão.Barberino., 2006:
Antimicrobial susceptibility of aerobic bacteria isolated from leishmaniotic ulcers in Corte de Pedra, BA

Dzierzanowska-Fangrat, K.; Semczuk, K.; Łopaciuk, U.; Kurlenda, J.; Małafiej, E.; Puacz, E.; Stalmaska-Dworak, E.; Dzierzanowska, D., 2005:
Antimicrobial susceptibility of aerobic microorganisms isolated from intraabdominal infections in pediatric patients in Poland

Mattos Filho, T.R.; Groppo, F.C.; Pacheco, A.B.N.D.; Motta, R.H.L.; Napimoga, M.H., 2005:
Antimicrobial susceptibility of air-dispersed microorganisms in dental settings

Roberts, S.A.; Shore, K.P.; Paviour, S.D.; Holland, D.; Morris, A.J., 2006:
Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003

García, A.D.; Ibarra, A.; Rodríguez, F.C.; Casal, M., 2005:
Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis

Vandenberg, O.; Houf, K.; Douat, N.; Vlaes, L.; Retore, P.; Butzler, J-Paul.; Dediste, A., 2006:
Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium

Chen, H-Ming.; Chung, P-Wen.; Yu, Y-Jeng.; Tai, W-Ling.; Kao, W-Ling.; Chien, Y-Li.; Chiu, C-Hsun., 2004:
Antimicrobial susceptibility of common bacterial pathogens isolated from a new regional hospital in southern Taiwan

Danchaivijitr, S.; Dhiraputra, C.; Rongrungruang, Y.; Worajitr, M.; Jintanothaitavorn, D., 2006:
Antimicrobial susceptibility of community and hospital acquired bacteria

Losito, P.; Vergara, A.; Muscariello, l.T.; Ianieri, A., 2006:
Antimicrobial susceptibility of environmental Staphylococcus aureus strains isolated from a pigeon slaughterhouse in Italy

Sader, H.S.; Streit, J.M.; Fritsche, T.R.; Jones, R.N., 2006:
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)

Decoster, L.; Frans, J.; Blanckaert, H.; Lagrou, K.; Verhaegen, J., 2005:
Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals

Danielsen, M.; Wind, A.; Leisner, J.J.; Arpi, M., 2007:
Antimicrobial susceptibility of human blood culture isolates of Lactobacillus spp

Dias, R.; Louro, D.; Caniça, M., 2006:
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period

Clarke, P.; Murchan, S.; Smyth, E.G.; Humphreys, H., 2004:
Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland

Bravo, L.; Cabrera, R.; Cabrera, L.E.; Ramírez, M.; Castañeda, N.; Fernández, A.; Garrigó, E.; Silva, M., 2004:
Antimicrobial susceptibility of no-O1 Vibrio cholerae strains isolated from patients in Cuba

Stratchounski, L.S.; Rafalski, V.V., 2006:
Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2

Metan, Gökhan.; Zarakolu, P.; Hasçelik, Gülşen.; Akova, M., 2006:
Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates

Reyes, M.S.; Durán, C.T.; Prado, V.J., 2005 :
Antimicrobial susceptibility of shiga toxin producing E coli (STEC) strains isolated from human infections and food

Hoeger, P.H., 2004:
Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis

Poletto, K.Queiroz.; Reis, C., 2005:
Antimicrobial susceptibility of the uropathogens in out patients in Goiânia City, Goiás State

Baserisalehi, M.; Al-Mahdi, A.Y.; Kapadnis, B.P., 2005:
Antimicrobial susceptibility of thermophilic Campylo-bacter spp. isolated from environmental samples

Vallano, A.; Rodríguez, D.; Barceló, M.Estrella.; López, A.; Cano, A.; Viñado, Bén.; Diogene, E., 2006:
Antimicrobial susceptibility of uropathogens and outcome following antibiotic treatment for urinary tract infections in primary health care

Grover, S.S.; Sharma, M.; Pasha, S.T.; Singh, G.; Lal, S., 2005:
Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi

Aspevall, O.; Lundberg, A.; Burman, L.G.; Akerlund, T.; Svenungsson, B., 2006:
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital

Asrat, D.; Kassa, E.; Mengistu, Y.; Nilsson, I.; Wadström, T., 2006:
Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Addis Ababa, Ethiopia

Akujobi, C.N., 2006:
Antimicrobial susceptibility pattern of Klebsiella species from Ebonyi State University Teaching Hospital Abakaliki, Nigeria

Urassa, W.K.; Mhando, Y.B.; Mhalu, F.S.; Mjonga, S.J., 2003:
Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania

Arya, M.; Arya, P.K.; Biswas, D.; Prasad, R., 2006:
Antimicrobial susceptibility pattern of bacterial isolates from post-operative wound infections

Mahapatra, A.; Samal, B.; Pattnaik, D.; Mishra, S.; Ghosh, S.K., 2004:
Antimicrobial susceptibility pattern of clinical isolates of non-fermentative bacteria

Zarakolu, P.; Hasçelik, Gülşen.; Unal, S., 2006:
Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)

Shittu, A.O.; Lin, J., 2006:
Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa

de Melo, M.Celeste.Nunes.; Sá Figueiredo, A.Marie.; Ferreira-Carvalho, B.Teixeira., 2003:
Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978-1997 in different Brazilian cities

Daoud, Z.; Cocozaki, A.; Hakime, N., 2006:
Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004

Matynia, B.; Młodzinska, E.; Hryniewicz, W., 2005:
Antimicrobial susceptibility patterns of Staphylococcus aureus in Poland obtained by the National Quality Assurance Programme

Quiñones-Falconi, F.; Calva, J.José.; López-Vidal, Y.; Galicia-Velazco, M.; Jiménez-Martinez, Mía.Elena.; Larios-Mondragón, L., 2004:
Antimicrobial susceptibility patterns of Streptococcus pneumoniae in Mexico

Subedi, S.; Brahmadathan, K.N., 2005:
Antimicrobial susceptibility patterns of clinical isolates of Staphylococcus aureus in Nepal

Orrett, F.A., 2004:
Antimicrobial susceptibility patterns of group B Streptococci isolated from pregnant women in Trinidad, West Indies

Dhawan, B.; Mohanty, S.; Das, B.K.; Kapil, A., 2004:
Antimicrobial susceptibility patterns of staphylococci in a tertiary care hospital

Orrett, F.A., 2003:
Antimicrobial susceptibility patterns of urinary pathogens in Trinidad, 1996-1999

Biedenbach, D.J.; Stephen, J.M.; Jones, R.N., 2003:
Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program--North America, 2001

Matsuzaki, K.; Watabe, E.; Furuki, A.; Kanayama, A.; Hasegawa, M.; Sato, Y.; Kobayashi, I., 2005:
Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004

MacKenzie, F.M.; Bruce, J.; Van Looveren, M.; Cornaglia, G.; Gould, I.M.; Goossens, H., 2006:
Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study

Swenson, J.M.; Killgore, G.E.; Tenover, F.C., 2004:
Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods

Kietzmann, M.; Böttner, A.; Hafez, H.Mohamed.; Kehrenberg, C.; Klarmann, D.; Krabisch, P.; Kühn, T.; Luhofer, G.; Richter, A.; Schwarz, S.; Traeder, W.; Waldmann, K-Heinz.; Wallmann, Jürgen.; Werckenthin, C., 2004:
Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint

Schwarz, S.; Böttner, A.; Hafez, H.M.; Kehrenberg, C.; Kietzmann, M.; Klarmann, D.; Klein, Günter.; Krabisch, P.; Kühn, T.; Luhofer, G.; Richter, A.; Traeder, W.; Waldmann, K-Heinz.; Wallmann, Jürgen.; Werckenthin, C., 2003:
Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications

Hoshino, T.; Sudo, F.; Sawada, K.; Sueyoshi, S.; Nakamura, A., 2005:
Antimicrobial susceptibility testing of clinical isolates of Haemophilus influenzae derived from Japanese children

Wada, S.; Matsuda, M.; Shingaki, M.; Kai, A.; Takahashi, S.; Itoh, T., 2003:
Antimicrobial susceptibility tests and resistant strain of Helicobacter pylori

Mendes, C.; Kiffer, C.R.V.; Blosser-Middleton, R.S.; Jones, M.E.; Karlowsky, J.A.; Barth, A.; Rossi, F.; Andrade, S.; Sader, H.S.; Thornsberry, C.; Sahm, D.F., 2004:
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002

Putnam, S.D.; Frenck, R.W.; Riddle, M.S.; El-Gendy, A.; Taha, N.N.; Pittner, B.T.; Abu-Elyazeed, R.; Wierzba, T.F.; Rao, M.R.; Savarino, S.J.; Clemens, J.D., 2004:
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea

Ghilardi, A.Cristina.Rodrigues.; Tavechio, A.Terezinha.; Fernandes, S.Aparecida., 2006:
Antimicrobial susceptibility, phage types, and pulse types of Salmonella Typhimurium, in São Paulo, Brazil

Panigrahi, D.; Chugh, T.D.; West, P.W.J.; Dimitrov, T.Z.; Groover, S.; Mehta, G., 2003:
Antimicrobial susceptibility, phage typing and plasmid profile of Salmonella enterica serotype paratyphi A strains isolated in Kuwait

Greenfield, R.A.; Cooper, T.W.; Bronze, M.S., 2006:
Antimicrobial symposium. Part 1. Principles of antimicrobial therapy

Cooper, T.W.; Gibbs, W.J.; Bronze, M.S.; Greenfield, R.A., 2007:
Antimicrobial symposium. Part IV. Cephalosporins

Höfer, D., 2006:
Antimicrobial textiles - evaluation of their effectiveness and safety

Höfer, D., 2006:
Antimicrobial textiles, skin-borne flora and odour

Nava-Ocampo, A.A.; Mojica-Madera, Jé.A.; Villanueva-García, D.; Caltenco-Serrano, Rúl., 2006:
Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis

Meyer, K.F., 1962:
Antimicrobial therapy and prophylactic immunization in the control of psittacosis or Bedsonia infection in show birds

Hutchison, L.C., 2004:
Antimicrobial therapy and resistance in dermatologic pathogens of the elderly

Gonzalez Avila, A., 1961:
Antimicrobial therapy as a preventive measure in primary tuberculosis

Nicodemo, A.C.; Paez, J.I.Garcia., 2007:
Antimicrobial therapy for Stenotrophomonas maltophilia infections

Tanaka, A.; Takada, T.; Kawarada, Y.; Nimura, Y.; Yoshida, M.; Miura, F.; Hirota, M.; Wada, K.; Mayumi, T.; Gomi, H.; Solomkin, J.S.; Strasberg, S.M.; Pitt, H.A.; Belghiti, J.; de Santibanes, E.; Padbury, R.; Chen, M-Fu.; Belli, G.; Ker, C-Guo.; Hilvano, S.C.; Fan, S-Tat.; Liau, K-Hin., 2007:
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

Yoshida, M.; Takada, T.; Kawarada, Y.; Tanaka, A.; Nimura, Y.; Gomi, H.; Hirota, M.; Miura, F.; Wada, K.; Mayumi, T.; Solomkin, J.S.; Strasberg, S.; Pitt, H.A.; Belghiti, J.; de Santibanes, E.; Fan, S-Tat.; Chen, M-Fu.; Belli, G.; Hilvano, S.C.; Kim, S-Whe.; Ker, C-Guo., 2007:
Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines

Don, D.M.; Goldstein, N.A.; Crockett, D.M.; Ward, S.Davidson., 2005:
Antimicrobial therapy for children with adenotonsillar hypertrophy and obstructive sleep apnea: a prospective randomized trial comparing azithromycin vs placebo

Papich, M.G., 2004:
Antimicrobial therapy for gastrointestinal diseases

Laterre, P.F.; Colardyn, F.; Delmée, M.; D.W.ele, J.; Legrand, J.C.; Van Eldere, J.; Vergison, A.; Vogelaers, D., 2006:
Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB)

Koibuchi, T.; Iwamoto, A., 2006:
Antimicrobial therapy for patients with HIV infection

Cantón, R.; Cobos, N.; de Gracia, J.; Baquero, F.; Honorato, J.; Gartner, S.; Alvarez, A.; Salcedo, A.; Oliver, A.; García-Quetglas, E., 2005:
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients

Takaro, T., 1955:
Antimicrobial therapy for pulmonary tuberculosis

Cohn, I., 1961:
Antimicrobial therapy for surgical gastrointestinal diseases

Breese, B.B., 1956:
Antimicrobial therapy in cardiovascular infections

Simon, A.; Schildgen, O., 2006:
Antimicrobial therapy in childhood asthma and wheezing

Pea, F.; Viale, P.; Furlanut, M., 2005:
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

Sunderkötter, C.; Herrmann, M.; Jappe, U., 2006:
Antimicrobial therapy in dermatology

Kohlenbrener, R.M.; Kunstadter, R.H., 1956:
Antimicrobial therapy in gastrointestinal tract infections

Campbell, M.F., 1956:
Antimicrobial therapy in genitourinary tract infections

Linde, L.M., 1961:
Antimicrobial therapy in heart disease in children

Hinshaw, H.C., 1950:
Antimicrobial therapy in human tuberculosis

Altemeier, W.A.; Wulsin, J.H., 1960:
Antimicrobial therapy in infured patients

Wilbur, K.; Sidhu, K., 2005:
Antimicrobial therapy in patients with acute variceal hemorrhage

Erdem, H.; Pahsa, A.; Oncu, S., 2006:
Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey

Wickstrom, J.; Ledbetter, R.H.; Campbell, E.R., 1960:
Antimicrobial therapy in pyogenic infections of the skeletal system

Rountree, P.M.; Grigor, W.G., 1961:
Antimicrobial therapy in staphylococcal disease of children

Eichenwald, H.F.; Shinefield, H.R., 1961:
Antimicrobial therapy in the neonatal period

Sutherland, J.M.; Mohlman, Y.M., 1961:
Antimicrobial therapy in the newborn infant: a major area of ignorance

Bouza, E.; Burillo, A.; Muñoz, P., 2006:
Antimicrobial therapy of Clostridium difficile-associated diarrhea

Flippin, H.F., 1953:
Antimicrobial therapy of bacterial pneumonias

File, T.M.; Niederman, M.S., 2004:
Antimicrobial therapy of community-acquired pneumonia

Bertz, H.; Auner, H.W.; Weissinger, F.; Salwender, H-Jürgen.; Einsele, H.; Egerer, G.; Sandherr, M.; Schüttrumpf, S.; Südhoff, T.; Maschmeyer, G., 2003:
Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Katz, Y.J.; Bourdo, S.R., 1961:
Antimicrobial therapy of genitourinary tract infections

Wallner, L.J., 1952:
Antimicrobial therapy of laryngeal tuberculosis

Griffith, M.E.; Hospenthal, D.R.; Murray, C.K., 2006:
Antimicrobial therapy of leptospirosis

Finland, M., 1955:
Antimicrobial therapy of meningococcal infections

Cunha, B.A., 2006:
Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus

Van Rooyen, C.E.; Dickson, R.C., 1959:
Antimicrobial therapy of non-tuberculous pulmonary infection

Storey, P.B.; Wier, J.A., 1956:
Antimicrobial therapy of pulmonary tuberculosis; current status

Stoycheva, M.V.; Murdjeva, M.A., 2006:
Antimicrobial therapy of salmonelloses--current state and perspectives

Vandow, J.E., 1959:
Antimicrobial therapy of syphilis

Robitzek, E.H., 1959:
Antimicrobial therapy of tuberculosis

Hinshaw, H.C., 1952:
Antimicrobial therapy of tuberculosis in 1952

Link, H.; Böhme, A.; Cornely, O.A.; Höffken, K.; Kellner, O.; Kern, W.V.; Mahlberg, R.; Maschmeyer, G.; Nowrousian, M.R.; Ostermann, H.; Ruhnke, M.; Sezer, O.; Schiel, X.; Wilhelm, M.; Auner, H.W., 2003:
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)

Tokarz, A.; Kozioł-Montewka, M.; Rutyna, Rł.; Chudnicka, A.; Sidor-Wójtowicz, A., 2003:
Antimicrobial therapy of upper respiratory tract infections in children

Donnelly, J.Peter.; Bellm, L.A.; Epstein, J.B.; Sonis, S.T.; Symonds, R.Paul., 2003:
Antimicrobial therapy to prevent or treat oral mucositis

Persson, G.Rutger.; Salvi, G.E.; Heitz-Mayfield, L.J.A.; Lang, N.P., 2006:
Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of peri-implantitis. I: Microbiological outcomes

Tompsett, R., 1958:
Antimicrobial therapy: the concurrent administration of two drugs

Liu, P.; Derendorf, H., 2004:
Antimicrobial tissue concentrations

Ewald, A.; Glückermann, S.K.; Thull, R.; Gbureck, U., 2006:
Antimicrobial titanium/silver PVD coatings on titanium

Kudva, Y.C., 2003:
Antimicrobial treatment did not reduce complications of urinary tract infection in diabetes and asymptomatic bacteriuria

Carter, J.D.; Valeriano, J.; Vasey, F.B., 2005:
Antimicrobial treatment for Chlamydia induced reactive arthritis

Deen, J.L.; Clemens, J.D., 2005:
Antimicrobial treatment for cholera

Finland, M., 1952:
Antimicrobial treatment for viral and related infections. I. Antibiotic treatment of primary atypical pneumonia

Finland, M., 1952:
Antimicrobial treatment for viral and related infections. II. Antibiotic treatment of acute respiratory infections and influenza

Anon, J.B.; Jacobs, M.R.; Poole, M.D.; Ambrose, P.G.; Benninger, M.S.; Hadley, J.A.; Craig, W.A., 2004:
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis

Kirshner, J.J., 1956:
Antimicrobial treatment in tuberculosis

Torres Martí, A.; Quintano Jiménez, J.A.; Martínez Ortiz de Zárate, M.; Rodríguez Pascual, C.; Prieto, J.; Zalacaín, R., 2006:
Antimicrobial treatment of COPD in the elderly

Vallano Ferraz, A.; Danés Carreras, I.; Ochoa Sangrador, C., 2004:
Antimicrobial treatment of bronchial infections in hospital emergency rooms

Restrepo, M.I.; Anzueto, A., 2005:
Antimicrobial treatment of community-acquired pneumonia

Fagon, J-Yves.; Chastre, J., 2005:
Antimicrobial treatment of hospital-acquired pneumonia

Heitz-Mayfield, L.J.A.; Lang, N.P., 2005:
Antimicrobial treatment of peri-implant diseases

Wagenlehner, F.Me.; Naber, K.G., 2004:
Antimicrobial treatment of prostatitis

Pitts, F.W.; Tempel, C.W., 1952:
Antimicrobial treatment of pulmonary tuberculosis

Grossi, P.; Gasperina, D.Dalla., 2006:
Antimicrobial treatment of sepsis

Jancik, E., 1960:
Antimicrobial treatment of tuberculosis in Czechoslovakia-papers from 1953 to 1958

Kendig, E.L., 1961:
Antimicrobial treatment of tuberculosis in childhood

Schaefer, G., 1959:
Antimicrobial treatment of tuberculous salpingitis

Berntsen, C.A., 1958:
Antimicrobial treatment of upper respiratory inflammation

Park, D.R., 2005:
Antimicrobial treatment of ventilator-associated pneumonia

Oberholzer, C.M.; Caserta, M.T., 2005:
Antimicrobial update: Daptomycin

Drinka, P.J.; Gauerke, C.; Le, D., 2004:
Antimicrobial use and methicillin-resistant Staphylococcus aureus in a large nursing home

Bassetti, M.; Cruciani, M.; Righi, E.; Rebesco, B.; Fasce, R.; Costa, A.; Molinari, M.P.; Mengoli, C.; Bobbio Pallavicini, F.; Viscoli, C., 2006:
Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit (ICU)

Ramírez Villaseñor, I., 2005:
Antimicrobial use in acute upper respiratory infections in family medicine

Angulo, F.J.; Baker, N.L.; Olsen, S.J.; Anderson, A.; Barrett, T.J., 2004:
Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans

Carnevale, R.A., 2005:
Antimicrobial use in food animals and human health

Akter, F.U.; Heller, D.; Smith, A.; Rahman, M.M.; Milly, A.F., 2004:
Antimicrobial use in paediatric wards of teaching hospitals in Bangladesh

White, P.H.; Kuhlenschmidt, H.L.; Vancura, B.G.; Navari, R.M., 2003:
Antimicrobial use in patients with advanced cancer receiving hospice care

Richards, C.L.; Darradji, M.; Weinberg, A.; Ouslander, J.G., 2005:
Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia

Allaouchiche, B., 2004:
Antimicrobial use in severe nosocomial infectious: arguments against empirical monotherapy

Das, B.P.; Sethi, A.; Rauniar, G.P.; Sharma, S.K., 2006:
Antimicrobial utilization pattern in out patient services of ENT department of tertiary care hospital of Eastern Nepal

Dickson, R.A.; Houghton, P.J.; Hylands, P.J.; Gibbons, S., 2006:
Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. and Microglossa pyrifolia Lam

Billia, P.; Biano, F., 1963:
Antimicrobial-corticosteroid treatment in pulmonary tuberculosis. Its remote results

Wedel, S.D.; Bender, J.B.; Leano, F.T.; Boxrud, D.J.; Hedberg, C.; Smith, K.E., 2006:
Antimicrobial-drug susceptibility of human and animal Salmonella typhimurium, Minnesota, 1997-2003

Heide, M.; Möhring, U.; Hänsel, R.; Stoll, M.; Wollina, U.; Heinig, B., 2006:
Antimicrobial-finished textile three-dimensional structures

Giamarellos-Bourboulis, E.J.; Perdios, J.; Gargalianos, P.; Kosmidis, J.; Giamarellou, H., 2003:
Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis

Richards, C.L.; Steele, L., 2003:
Antimicrobial-resistant bacteria in long-term care facilities: infection control considerations

Salzer, W., 2005:
Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them

Marcus, H.; Christopoulos, P., 1960:
Antimicrobial-steroid treatment of active pulmonary tuberculosis as a routine measure

Olansky, S., 1961:
Antimicrobial-steroid-tar combination in treatment of subacute and chronic dermatoses

Kass, I.; Mandel, W.; Russell, W.F., 1956:
Antimicrobially active concentrations of salizid and isoniazid in the blood

Eifler-Bollen, R.; Fluhr, J.W., 2005:
Antimicrobially effective compounded medications. Clinical value and critical comments

Elsner, P., 2006 :
Antimicrobials and the skin physiological and pathological flora

Dörfer, C.E., 2003:
Antimicrobials for the treatment of aggressive periodontitis

Ripoll, M.A., 2003:
Antimicrobials in primary care. Scenario and identification of problems

Thurston, D.L.; Oda, R.E.; Tsifutis, A.A., 1962:
Antimicrobials in respiratory tract infections

Witkowski, J.A.; Parish, L.Charles., 2003:
Antimicrobials in the treatment of acne and rosacea

Barasch, A.; Elad, S.; Altman, A.; Damato, K.; Epstein, J., 2006:
Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis

Pastore, P.N.; Hench, M.E., 1960:
Antimicrobials, tonsil and adenoid bacteriology, and blood culture findings before and after tonsillectomy and adenoidectomy

Cañada Merino, J.L., 2003:
Antimicrobials. Is etiologic treatment possible in primary care?

Cisneros-Farrar, F.; Parsons, L.C., 2007:
Antimicrobials: classifications and uses in critical care

Liautard, J-Pierre.; Jubier-Maurin, Véronique.; Boigegrain, R-Anne.; Köhler, S., 2006:
Antimicrobials: targeting virulence genes necessary for intracellular multiplication

Lepper, M.H., 1960:
Antimicrobials: the two-edged sword

Sabalitschka, T., 1950:
Antimicrobic action of fatty oils

Welsch, M.; Urbain, M., 1950:
Antimicrobic properties of tri-glycolic ether of acetoxy-mercuricphenol

Virtanen, A.I., 1958:
Antimicrobiological substances in cultivated plants and their significance for other plants and for human and animal nutrition

Ourgaud, A.G.; Mosse, P., 1956:
Antimicrophthalmic contact lens

Oelkers, W., 2003:
Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone

André, N.; Rome, A.; Carré, M., 2005:
Antimitochondrial agents: a new class of anticancer agents

Bogdanos, D-Petrou.; Baum, H.; Vergani, D., 2003:
Antimitochondrial and other autoantibodies

Pinelli, M.; Bindi, M.; Moroni, F.; Rosada, J.; Castiglioni, M., 2006:
Antimitochondrial antibodies and non-Hodgkin lymphoma presenting as hepatobiliary disease

Ramos-Casals, M.; Pares, A.; Jara, L-J.; Solans, R.; Viñas, O.; Vázquez, P.; Sánchez-Tapias, J-M.; Rodés, J.; Font, J., 2005:
Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature

Ranua, J.; Luoma, K.; Auvinen, A.; Haapala, A-Maija.; Mäki, M.; Peltola, J.; Raitanen, J.; Isojärvi, J.I., 2005 :
Antimitochondrial antibodies in patients with epilepsy

Sakauchi, F.; Mori, M.; Zeniya, M.; Toda, G., 2005:
Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid

Balch, C.; Yan, P.; Craft, T.; Young, S.; Skalnik, D.G.; Huang, T.H-M.; Nephew, K.P., 2005:
Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer

Santa María Margalef, A.; Paciucci Barzanti, R.; Reventós Puigjaner, J.; Morote Robles, J.; Thomson Okatsu, T.M., 2003:
Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia

Sforza, M., 1964:
Antimitotic Chemotherapy in Patients with Malignant Tumors, as the only Treatment in Inoperable Cases and as An Association to Surgical Removal

Rondanelli, R.; Magliulo, E.; Morandini, G.C.; Vannini, V., 1964:
Antimitotic Effect of Neosalvarsan on Erythropoietic Cells

Truhaut, R.; Deysson, G., 1965:
Antimitotic Properties of Quinazolone Derivatives. 3. 1-Methyl-1,4-Dihydro-4-Quinazolone and 1-N-Propyl-1,4-Dihydro-4-Quinazolone

Truhaut, R.; Deysson, G., 1965:
Antimitotic Properties of Quinazolone Derivatives. I. 3-Methyl 3,4-Dihydro-4-Quinazolone and Iodomethylated Derivative

Deysson, G.; Truhaut, R., 1965:
Antimitotic Properties of Quinazolone Derivatives. Ii. 3-Ehyl-, 3-N-Propyl- and 3-Isopropyl-3,4-Dihydro-4-Quinazolone

Okada, T.A.; Roberts, E., 1962:
Antimitotic action of 5-(2'-bromo-acetamido)-uracil on the Ehrlich ascites tumor

Beltrami, L., 1958:
Antimitotic action of thallium chloride on vegetative apices of Allium cepa L

Dustin, P., 1950:
Antimitotic action, in the mouse, of lactate of 2-6 diaminopurine

Jequier, R.; Branceni, D.; Peterfalvi, M., 1955:
Antimitotic activity and toxicity of some derivatives of colchicine and thiocolchicine

Truhaut, R.; Deysson, G., 1957:
Antimitotic activity in the urethane series. III. Cyclic urethanes (oxazolidone & derivatives)

Deysson, G.; Truhaut, R., 1957:
Antimitotic activity in the urethane series. IV. Cyclic thiourethanes

Stoerk, H.C.; Arison, R.N.; Hawkins, J.E., 1957:
Antimitotic activity of 5-tertiary butyl benzimidazolone

Clerici, E.; Monesi, V.; Veronesi, U., 1955:
Antimitotic activity of a new actinomycin preparation in vitro chick embryo fibroblast culture

Costa, E.; Ferrari, W., 1954:
Antimitotic activity of a polysulfonated azo dye after suppression, by chemical means, of its capacity of staining tissues

Giolitti, G., 1962:
Antimitotic activity of antifungal antibiotics

Miltyk, W.; Palłka, M.; Karna, E.; Jarzabek, K.; Boujrad, N.; Knapp, P., 2007:
Antimitotic activity of high affinity ligands for peripheral benzodiazepine receptor (PBR) in some normal and neoplastic cell lines

Erede, P., 1957:
Antimitotic activity of potassium cyanate on experimental Galliera sarcoma

Giornelli, C.; Lauro, V.; Fanelli, A., 1963:
Antimitotic agents and fertility: experimental research. I. Results of treatment of rats and mice with cyclophosphoramide

Gastaldi, G., 1955:
Antimitotic agents and nerve regeneration: preliminary note

Debray, J., 1963:
Antimitotic agents in human therapeutics

Nagle, A.; Hur, W.; Gray, N.S., 2006:
Antimitotic agents of natural origin

Sentein, P., 1957:
Antimitotic and teratogenic action of sodium para-aminosalicylate in Triturus helveticus Raz

Loustalot, P.; Schar, B.; Meier, R., 1955:
Antimitotic and tumor-inhibiting properties of an internal salt of 2,5-bis-ethyleniminohydroquinone

Giambelli, G.; Ruffoni, R., 1962:
Antimitotic antibiotic and the taking of experimental bone grafts

Brugsch, J., 1950:
Antimitotic cellulotoxins as a clinical problem

Deysson, G.; Rollen, A., 1951:
Antimitotic effect of maleic hydrazide

Bianco, R.; Talamazzi, F., 1955:
Antimitotic effect of triethylene melamine and 2 new hydrazines on Allium cepa

Friedheim, E., 1961:
Antimitotic effects of dithia-arsa compounds

Marinone, G., 1952:
Antimitotic medication; present state of knowledge on nitrogen mustards and nitrogen mustards simulants

Hamel, E.; Covell, D.G., 2003:
Antimitotic peptides and depsipeptides

Truhaut, R.; Deysson, G., 1957:
Antimitotic properties of cyclic urethanes and thiourethanes

Deysson, G.; Truhaut, R., 1957:
Antimitotic properties of urethane glycol and various derivatives

Huffman, M.N.; Jones, R.W.; Katzberg, A.A., 1957:
Antimitotic steroidal estrogens

Cucinotta, U.; Dibernardo, N., 1963:
Antimitotics and Homologous Grafts

Fumarola, D., 1956:
Antimitotics and blood coagulation

Lord, C.F.; Husa, W.J., 1954:
Antimolding agents for syrups

Oliveira Neto, M.Paes.de., 2005:
Antimonial treatments of leishmaniasis

Djuric, D., 1963:
Antimony Metabolism

Baroni, F.; Boscagli, A.; Protano, G.; Riccobono, F., 2004:
Antimony accumulation in Achillea ageratum, Plantago lanceolata and Silene vulgaris growing in an old Sb-mining area

Dawson, M.; Doble, P.; Beavis, A.; Li, L-Xi.L.; Soper, R.; Scolyer, R.A.; Uren, R.F.; Thompson, J.F., 2003:
Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients

Sen Gupta, P.C.; Chatterji, A.; Mukherjee, A.M., 1961:
Antimony dextran complex in the treatment of leishmaniasis

Huang, Y.; Ruiz, P., 2006:
Antimony dispersion and phase evolution in the Sb2O3-Fe2O3 system

Piorkowski, G., 1956:
Antimony for treatment of lymphogranulomatosis

Garb, J., 1949:
Antimony preparations in the treatment of mycosis fungoides

Mirzoian, N.A., 1957:
Antimony resistance in the treatment of visceral leishmaniasis

Milet, J.C.C., 1953:
Antimony therapy of schistosomiasis mansoni

Geng, J.; Lu, D.; Zhu, J-Jie.; Chen, H-Yuan., 2006:
Antimony(III)-doped PbWO4 crystals with enhanced photoluminescence via a shape-controlled sonochemical route

Hermann, Rël.P.; Grandjean, F.; Chen, T-Chi.; Brown, D.E.; Johnson, C.E.; Snyder, G.Jeffrey.; Long, G.J., 2007:
Antimony-121 Mössbauer spectral study of alpha-Zn4Sb3

Waterman, R.; Tilley, T.Don., 2006:
Antimony-antimony bond formation by reductive elimination from a hafnium bis(stibido) complex

Abdo, M.G.; Elamin, W.M.; Khalil, E.A.G.; Mukhtar, M.M., 2005:
Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation

Balázs, Gábor.; Sierka, M.; Scheer, M., 2005:
Antimony-tungsten triple bond: a stable complex with a terminal antimony ligand

McCarty, K.M.; Senn, D.B.; Kile, M.L.; Quamruzzaman, Q.; Rahman, M.; Mahiuddin, G.; Christiani, D.C., 2004:
Antimony: an unlikely confounder in the relationship between well water arsenic and health outcomes in Bangladesh

Shotyk, W.; Krachler, M.; Chen, B., 2005:
Antimony: global environmental contaminant

Anonymous, 1952:
Antimosquito control by spraying of DDT

Kay, G.G.; Granville, L.J., 2005:
Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly

Dawson, L.; Tobin, A.; Smith, P.; Gordon, T., 2005:
Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?

Dawson, L.J.; Stanbury, J.; Venn, N.; Hasdimir, B.; Rogers, S.N.; Smith, P.M., 2006:
Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells

Drinka, P.J., 2006:
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients

Winder, A., 2005:
Antimuscarinic management of overactive bladder

Macdiarmid, S., 2006:
Antimuscarinic therapy for the treatment of mixed incontinence

Staskin, D.R.; Kaplan, S.A.; Wein, A.J., 2006:
Antimuscarinic therapy in men with bladder outlet obstruction

Dmochowski, R., 2006:
Antimuscarinic therapy in men with lower urinary tract symptoms: what is the evidence?

De Ridder, D., 2006:
Antimuscarinics and cognitive function

Hegde, S.S.; Mammen, M.; Jasper, J.R., 2004:
Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies

Andersson, K-Erik., 2003:
Antimuscarinics for treatment of overactive bladder

Dvornyk, A.S.; Pererva, T.P.; Kunakh, V.A., 2005:
Antimutagenesis as organism defense system against damaging factors of endogenous and exogenous origin

Agabeĭli, R.A.; Kasimova, T.E., 2005:
Antimutagenic activity of Armoracia rusticana, Zea mays and Ficus carica plant extracts and their mixture

Tangvarasittichai, S.; Sriprang, N.; Harnroongroj, T.; Changbumrung, S., 2006:
Antimutagenic activity of Sesbania javanica Miq. flower DMSO extract and its major flavonoid glycoside

Park, K-Young.; Jung, G-Ok.; Lee, K-Tae.; Choi, J.; Choi, M-Young.; Kim, G-Tae.; Jung, H-Ju.; Park, H-Juhn., 2003:
Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua

Avchieva, P.B.; Tyurenkov, V.A.; Butorova, I.A.; Deev, S.V.; Avchiev, M.I.; Kulakova, A.V.; Durnev, A.D., 2004:
Antimutagenic activity of lipidovit

Agabeĭli, R.A.; Kasimova, T.E.; Alekperov, U.K., 2004:
Antimutagenic activity of plant extracts from Armoracia rusticana, Ficus carica and Zea mays and peroxidase in eukaryotic cells

Zasukhina, G.D.; Vasil'eva, I.M.; Mikhal'chik, E.S.; Durnev, A.D.; Gromov, S.P.; Fedorova, O.A.; Alfimov, M.V., 2003:
Antimutagenic and antioxidant activities of crown compounds in comparison with the effects of garlic extract

Zasukhina, G.D.; Vasil'eva, I.M.; Vedernikov, A.I.; Gromov, S.P.; Alfimov, M.V., 2006:
Antimutagenic characteristics of new diazacrown compounds with N-carboxyalkyl substitutes

Birosová, L.; Mikulásová, Mária.; Vaverková, Sánia., 2006:
Antimutagenic effect of phenolic acids

Taneja, P.; Arora, A.; Shukla, Y., 2003:
Antimutagenic effects of black tea in the Salmonella typhimurium reverse mutation assay

Park, K-Young.; Jung, K-Ok.; Rhee, S-Hee.; Choi, Y.Hyun., 2003:
Antimutagenic effects of doenjang (Korean fermented soypaste) and its active compounds

Zhang, H.; Jeong, B.S.; Ma, T.H., 2004:
Antimutagenic property of an herbal medicine, Polygonum multiftorum Thunb. detected by the Tradescantia micronucleus assay

Krutiakov, V.M., 2004:
Antimutagenic role of autonomous 3'-->5'-exonucleases

Pillai, S.P.; Mitscher, L.A.; Menon, S.R.; Pillai, C.A.; Shankel, D.M., 2004:
Antimutagenic/antioxidant activity of green tea components and related compounds

Kulwat, C.; Lertprasertsuke, N.; Leechanachai, P.; Kongtawelert, P.; Vinitketkumnuen, U., 2005:
Antimutagenicity and DT-diaphorase inducing activity of Gynostemma pentaphyllum Makino extract

Hiramatsu, N.; Xiufen, W.; Takechi, R.; Itoh, Y.; Mamo, J.; Pal, S., 2005:
Antimutagenicity of Japanese traditional herbs, gennoshoko, yomogi, senburi and iwa-tobacco

Fu, J-Yun.; Xia, Y.; Zheng, Y-Yan., 2005:
Antimutagenicity of propolis against some mutagens in vivo and in vitro

Weisburger, J.H., 2004:
Antimutagens, anticarcinogens, and effective worldwide cancer prevention

Schoenborn, C., 1964:
Antimycelian Effect of some Common Antimycotic Agents and Disfectants

Theologis, A.; Laties, G.G., 1978:
Antimycin-insensitive Cytochrome-mediated Respiration in Fresh and Aged Potato Slices

Waisser, K.; Bures, O.; Holý, P.; Kunes, J.; Oswald, R.; Jirásková, L.; Pour, M.; Klimesová, V.; Palát, K.; Kaustová, J.; Danse, H.M.; Möllmann, U., 2003 :
Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones

Urbancik, R.; Trnka, L.; Kruml, J.; Polenska, H., 1964:
Antimycobacterial Activity of Isoxyl. Ii. Experiments with Guinea Pigs and Rabbits

Trnka, L.; Urbancik, R.; Polenska, H., 1963:
Antimycobacterial Activity of Isoxyl. Studies in Vitro and Mice

Okamoto, K.; Terunuma, K., 1964:
Antimycobacterial Activity of Serum from Patient Under Chemotherapy

Sood, R.; Bhadauriya, T.; Rao, M.; Gautam, R.; Malhotra, S.; Barman, T.K.; Upadhyay, D.J.; Rattan, A., 2006:
Antimycobacterial activities of oxazolidinones: a review

Klugh, G.A.; Pratt, P.C.; Atwell, R.J., 1960:
Antimycobacterial activity of N-isonicotinyl hydrazide and cross resistance to isoniazid

Demikhova, O.V.; Balakshin, V.V.; Presnova, G.A.; Bocharova, I.V.; Lepekha, L.N.; Chernousova, L.N.; Smirnova, T.G.; Pospelov, L.E.; Chistiakov, A.N., 2006:
Antimycobacterial activity of a dry birch bark extract on a model of experimental pulmonary tuberculosis

Taylor, P.W., 2004:
Antimycobacterial activity of indigenous South African plants

Waisser, K.; Drazková, K.; Cizmárik, J.; Kaustová, J., 2004:
Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids

Nitti, V., 1963:
Antimycobacterial activity of rifamycin SV in vitro

Malinka, Wław.; Redzicka, A.; Swiatek, P., 2003:
Antimycobacterial activity of some pyrido-1,2-thiazine derivatives

Demkow, U.; Filewska, Młgorzata.; Białas, B.; Szturmowicz, M.; Zielonka, T.; Wesołowski, S.; Kuś, J.; Ziołkowski, J.; Augustynowicz-Kopeć, E.; Zwolska, Z.; Skopińiska-Rábewska, E.; Rowińska-Zakrzewska, E., 2005:
Antimycobacterial antibody level in pleural, pericardial and cerebrospinal fluid of patients with tuberculosis

Copp, B.R., 2004:
Antimycobacterial natural products

Grunberg, E.; Schnitzer, R.J., 1953:
Antimycobacterial properties of a new derivative of isoniazid

Kawata, N.; Kawahara, S.; Tada, A.; Takigawa, N.; Shibayama, T.; Soda, R.; Takahashi, K., 2006:
Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM

Roth, L., 1962:
Antimycosis therapy in general practice

Gpehrels, E., 1964:
Antimycotic and Antieczematous Treatment with a Dibromsalicylcortisteroid Combination

Nassi, L., 1955:
Antimycotic action in vitro of sodium ethyl thiosalicylate and of mercury on certain strains of Candida albicans

Geiser, J.D., 1955:
Antimycotic action of certain synthetic antihistaminics and other substances in vitro

Hosoya, S.; Soeda, M.; Imamura, S.; Okada, K.; Nakazawa, S.; Komatsu, N.; Kobori, T.; Ikenaga, M., 1954:
Antimycotic activities of trichomycin, with special reference to the experimental and clinical studies of trichomycin ointment

Volo, S., 1956:
Antimycotic activity of synthetic antihistaminics

García, M.Sánchez., 2006:
Antimycotic agent for the prevention of mycotic infections in non-neutropenic critical patients

Burkert, M.; Fuhr, H.G.; Mertelsmann, R., 1989:
Antimycotic combination therapy in patients with acute myeloblastic leukemia

Cleary, J.D.; Walker, L.A.; Hawke, R.L., 2005:
Antimycotic drug discovery in the age of genomics

Morellini, M.; Avegno, R.P., 1957:
Antimycotic drugs evaluated with the Galleria mellonella test

Nassi, L., 1955:
Antimycotic effect of a quaternary ammonium compound on certain strains of Candida albicans in vitro

Fragner, P.; Krauskopf, J., 1956:
Antimycotic effect of chinosol

Littman, M.L., 1955:
Antimycotic effect of chlorquinaldol

Uri, J.; Bognar, R.; Bekesi, I.; Balogh, M., 1955:
Antimycotic effect of p-hydroxybenzoic acid esters. I. Research in vitro

Schirren, C., 1957:
Antimycotic effects of a new type of rubber for shoes

Besta, B.; Valenti, S.; De Palma, M.; Licitra, V., 1957:
Antimycotic effects of nystatin on the fecal & bronchopulmonary flora in man

Varsanyi, D.; Florian, E., 1958:
Antimycotic effects of pentachlorophenol

Jung, H.D.; Schroeder, H., 1954:
Antimycotic efficacy of the plant extracts

Carrie, C., 1963:
Antimycotic impregnation of stockings and shoes

Fouda, M.M.G.; Knittel, D.; Hipler, U-Christina.; Elsner, P.; Schollmeyer, E., 2006:
Antimycotic influence of beta-cyclodextrin complexes--in vitro measurements using laser nephelometry in microtiter plates

Kaden, R., 1954:
Antimycotic lacquer in clinical and experimental studies

Winkler, A.; Schroeder, E., 1960:
Antimycotic ointments combined with corticosteroids

Peiser, B.; Weyer, H., 1959:
Antimycotic therapy with jadit in clinical & private practice

Janke, D., 1952:
Antimycotic therapy with special reference to fatty acids dissolved molecularly in leucichthol

Petersen, U.K., 1955:
Antimycotic treatment of interstitial pneumonia in infants

Holzgrabe, U.; Schäfer-Korting, M., 2003:
Antimycotics

Reichrath, Jörg., 2004:
Antimycotics: why are they effective in the treatment of seborrheic dermatitis?

Mantegazza, R., 2003:
Antimyelin antibodies in multiple sclerosis

Pelayo, R.; Tintoré, M.; Montalban, X.; Rovira, A.; Espejo, C.; Reindl, M.; Berger, T., 2007:
Antimyelin antibodies with no progression to multiple sclerosis

Mitsiades, C.S.; Mitsiades, N.S.; McMullan, C.J.; Poulaki, V.; Kung, A.L.; Davies, F.E.; Morgan, G.; Akiyama, M.; Shringarpure, R.; Munshi, N.C.; Richardson, P.G.; Hideshima, T.; Chauhan, D.; Gu, X.; Bailey, C.; Joseph, M.; Libermann, T.A.; Rosen, N.S.; Anderson, K.C., 2005:
Antimyeloma activity of heat shock protein-90 inhibition

Tomaszewicz-Libudzic, C.; Brzozowska, A.; Jagielska, G.; Komender, J., 2004:
Antimyocardial antibodies in anorexia nervosa

Kanthasamy, A.G..; Tith, T.; Nguyen, B.; Tran, A.; Truong, D.D.., 2003:
Antimyoclonic and neuroprotective effects of lamotrigine in an animal model of cardiac arrest

Mancuso, M.; Galli, R.; Pizzanelli, C.; Filosto, M.; Siciliano, G.; Murri, L., 2006:
Antimyoclonic effect of levetiracetam in MERRF syndrome

Sentein, P., 1957:
Antimytotic action of sodium ethylmercurythio-salicylate

Mohamed, K.Abdelhakim.; Davies, W.A.R.; Lashen, H., 2006:
Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate

Smeenk, J.M.J.; Sweep, F.C.G.J.; Zielhuis, G.A.; Kremer, J.A.M.; Thomas, C.M.G.; Braat, D.D.M., 2006:
Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection

KIMENIS, A.A.; BRITSE, M.A.; SHUSTER, I.Ia., 1964:
Antinarcotic Action of Bemegride and some Related Compounds

Patalova, V.N., 1963:
Antinarcotic action of analeptics in radiation injury

Gorelasvili, A.; Antelava, N., 2005:
Antinecrotic and antiischemic effect of mexidol and trental in ischemia of the skin graft

Baronchelli, A., 1956:
Antinecrotic and hepatoprotective action of methionine methylsulfide

Maevskii, M.M.; Urazova, A.P.; Romanenko, E.A.; Molkov, Y.N.; Bondareva, A.S.; Timofeevskaya, E.A.; Vyazova, O.I.; Mazaeva, V.G.; Talyzina, V.A., 1964:
Antineoplastic Action of Antibiotic Chrysomallin

Ioachim, H., 1963:
Antineoplastic Action of Malachite Green--An Experimental Study

Chernov, V.A.; Volodarskaia, S.M., 1963:
Antineoplastic Activity of Allylamides and Ethyleneimides of Phosphoric and Thiophosphoric Acid

Vermel, E.M.; Krugliak, S.A., 1963:
Antineoplastic Activity of Gossypol in Experimental Transplanted Tumors

Trusheikina, V.I., 1964:
Antineoplastic Activity of O-Bis(2-Chloroethyl) Amino-Dl-Phenylalanine (Orthosarcolysin)

Kravchenko, A.I., 1964:
Antineoplastic Activity of some Derivatives of Bis (Beta-Chlorethyl) Aminomethyl Azobenzene

Chernov, V.A.; Iashunskii, V.G., 1964:
Antineoplastic Activity of Sydnone Imines Under Experimental Conditions

Brown, K.L., 1965:
Antineoplastic Agents Derived from the Periwinkle Plant: Vinblastine Sulfate: (Velban)

Pettit, G.R.; Baumann, M.F.; Rangammal, K.N., 1962:
Antineoplastic Agents. V. the Aromatic System of Podophyllotoxin (Part B)

KRASHILINA, A.Ia., 1964:
Antineoplastic Alkaloids of Vinca Rosea Linn. (Review of the Literature)

AIZENMAN, B.Iu., 1963:
Antineoplastic Antibiotics

Bandiera, D., 1964:
Antineoplastic Chemotherapy

Cappellano, R., 1963:
Antineoplastic Chemotherapy by Arterial Infusion. Indications for the Treatment of Tumors of the Head and Neck

Pinheirolc De, 1963:
Antineoplastic Chemotherapy in An Isolated Circuit

Maijnelli, M., 1965:
Antineoplastic Chemotherapy In The Experience Of The Obstetric And Gynecologic Clinic Of The University Of Florence

Francova, V.; Raz, K.; Franc, Z.; Cerny, A.; Semonsky, M.; Jelinek, V., 1964:
Antineoplastic Drugs. Vii. Comparison of the Absorption, Tissue Distribution, and Excretion of 35s-Buthiopurin and its 35s-Butyl Ester in S 180 Sarcoma-Bearing Mice

Berdjis, C.C.; Howie, D.L.; Frank, W., 1964:
Antineoplastic Effect of Vee Virus in Mice. the Effect of Attenuated Venezuelan Equine Encephalomyelitis Virus on Mouse Leukosarcoma L1210

Arakawa, Y., 1964:
Antineoplastic Effects of 7-Membered Ring Compounds. 3. Antineoplastic Effects of 2-Isonicotinoyl Hydrazino-5-Nitrosotropone-N-Oxide (Rch-1003)

Vigi, F., 1963:
Antineoplastic Preparations Used as a Means of Protection Against the Free Elements in the Blood and Contamination by Neoplastic Cells, in Operative Interventions

Chernov, V.A.; Piskov, V.B.; Sorkina, I.A.; Lytkina, L.G.; Lytkina, V.B., 1962:
Antineoplastic activities of compounds containing ethylene bonds joined to carbonyl groups

Chernov, V.A.; Grushina, A.A.; Lytkina, L.G., 1963:
Antineoplastic activity of Fosfazin

Trusheikina, V.I., 1961:
Antineoplastic activity of beta-p-di(2-chloroethyl) aminophenyl-beta-alanine (beta-sarcolysin)

Swellam, T.; Miyanaga, N.; Onozawa, M.; Hattori, K.; Kawai, K.; Shimazui, T.; Akaza, H., 2003:
Antineoplastic activity of honey in an experimental bladder cancer implantation model: in vivo and in vitro studies

Chernov, V.A.; Lystkina, V.G., 1957:
Antineoplastic activity of tetraethylene-imidpiperazine-N, N'-diphosphoric acid (dipine)

Shorin, V.A.; Rossolimo, O.K.; Stanislavskaia, M.S.; Iibliumberg, N.A.; Filippos'ian, S.T.; Lepeshkina, G.N., 1962:
Antineoplastic activity of the antibiotic olivomycin

Schulz, H.; Bigelow, S.; Dobish, R.; Chambers, C.R., 2006:
Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective

Pettit, G.R.; Hoffmann, H.; Herald, D.L.; McNulty, J.; Murphy, A.; Higgs, K.C.; Hamel, E.; Lewin, N.E.; Pearce, L.V.; Blumberg, P.M.; Pettit, R.K.; Knight, J.C., 2004:
Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine

Muto, A.; Nakagawa, A.; Shimomura, Y.; Kitagawa, Y.; Tsurusawa, M., 2005:
Antineoplastic agents for pediatric anaplastic large cell lymphoma: Vinblastine is the most effective in vitro

Guren, T.K.; Christoffersen, T.; Thoresen, G.Hege.; Wisløff, F.; Dajani, O.; Tveit, K.M., 2005:
Antineoplastic agents targeting tyrosine kinases

Pettit, G.R.; Rhodes, M.R.; Herald, D.L.; Hamel, E.; Schmidt, J.M.; Pettit, R.K., 2005:
Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41

Pettit, G.R.; Hoffmann, H.; Herald, D.L.; Blumberg, P.M.; Hamel, E.; Schmidt, J.M.; Chang, Y.; Pettit, R.K.; Lewin, N.E.; Pearce, L.V., 2004:
Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine

Pettit, G.R.; Minardi, M.D.; Rosenberg, H.J.; Hamel, E.; Bibby, M.C.; Martin, S.W.; Jung, M.Katherine.; Pettit, R.K.; Cuthbertson, T.J.; Chapuis, J-Charles., 2005:
Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1)

Pettit, G.R.; Melody, N., 2005 :
Antineoplastic agents. 527. Synthesis of 7-deoxynarcistatin, 7-deoxy-trans-dihydronarcistatin, and trans-dihydronarcistatin 1(1)

Erlich, D., 1960:
Antineoplastic chemotherapy in the Soviet Union, West Germany, France, England and Italy

Leocani, B., 1961:
Antineoplastic chemotherapy in the treatment of malignant tumors of the female genitalia

Junqueira, A.C., 1963:
Antineoplastic chemotherapy. Purpose of its use in association with surgery and radiotherapy

Fellhauer, M.; Hecker, E., 1988:
Antineoplastic diterpene esters from thymelaeaceae species: therapeutic indices referring to irritancy

Larionov, L.F.; Platonova, G.N., 1955:
Antineoplastic effect of 4-methyl-5-di-(chloroethyl)-amino-uracil (dopane)

Nishiyama, U.; Yoshino, T.; Ozai, M.; Yoshioka, R.; Fujisawa, M.; Ogasawara, Y.; Kitahori, M.; Yoshioka, E.; Kubo, K.; Komeno, Y.; Kurokawa, M.; Ogawa, S.; Chiba, S.; Osawa, T.; Kuwaki, T.; Hirai, H.; Miwa, A., 2006:
Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations

Vartanian, L.P.; Ivanov, E.V.; Vershinina, S.F.; Markochev, A.B.; Bisenieks, E.A.; Gornaeva, G.F.; Pustovalov, I.I.; Ponomareva, T.V., 2004:
Antineoplastic effect of glutapyrone in continual gamma-irradiation of rats

Cevese, P.G.; Ferro, A., 1951:
Antineoplastic effect of normal tissue extracts; experimental research; preliminary note

Liu, H.; Fu, R-Yi.; Li, F-Yi.; Zhu, Y-Ping.; Wang, X-Yang.; Mao, Y-Qiu.; Wu, X-Zhen.; Zhou, C-Yan., 2006:
Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells

Freeman, H.J., 2004:
Antineoplastic effects of 5-aminosalicylates and potential cancer preventive role in inflammatory bowel disease

Wang, J-Hua.; Xing, Q-Tai.; Yuan, M-Biao., 2004:
Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro

Strair, R.K.; Schaar, D.; Medina, D.; Todd, M.B.; Aisner, J.; DiPaola, R.S.; Manago, J.; Knox, B.; Jenkinson, A.; Senzon, R.; Baker, C.; Liesel, D.; Ciardella, M.; Kuriyan, M.; Rubin, A.; Lattime, E.C., 2003:
Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma

Grommes, C.; Landreth, G.E.; Heneka, M.T., 2004:
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

Chavez-Blanco, A.; Perez-Plasencia, C.; Perez-Cardenas, E.; Carrasco-Legleu, C.; Rangel-Lopez, E.; Segura-Pacheco, B.; Taja-Chayeb, L.; Trejo-Becerril, C.; Gonzalez-Fierro, A.; Candelaria, M.; Cabrera, G.; Duenas-Gonzalez, A., 2006:
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

Hochwald, S.N.; Lind, D.Scott.; Malaty, J.; Copeland, E.M.; Moldawer, L.L.; MacKay, S.L.D., 2003:
Antineoplastic therapy in colorectal cancer through proteasome inhibition

Thompson, C.A., 2004:
Antineoplastics declared occupational hazard

Fujii, T.; Nakamura, A.M.; Yokoyama, G.; Yamaguchi, M.; Tayama, K.; Miwa, K.; Toh, U.; Kawamura, D.; Shirouzu, K.; Yamana, H.; Kuwano, M.; Tsuda, H., 2005:
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells

Block, K.I., 2004:
Antineoplastons and the challenges of research in integrative care

Eichler, W.; Yafai, Y.; Wiedemann, P.; Fengler, Dörte., 2006:
Antineovascular agents in the treatment of eye diseases

Shimizu, K.; Asai, T.; Oku, N., 2005:
Antineovascular therapy, a novel antiangiogenic approach

Kinnersley, H.W.; Peters, R.A., 1925:
Antineuritic Yeast Concentrates. I

Leong, P.C.; Harris, L.J., 1937:
Antineuritic potency of synthetic and natural crystalline vitamin B(1) as determined by the "bradycardia" method: With a statistical study of the degree of accuracy of the "bradycardia" method

Kinnersley, H.W.; Peters, R.A., 1928:
Antineuritic yeast concentrates: The further purification of yeast vitamin B(1) (curative)

Dasgupta, S.; Jana, M.; Zhou, Y.; Fung, Y.K.; Ghosh, S.; Pahan, K., 2004:
Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis

Benyahia, B.; Carpentier, A.F.; Delattre, J-Y., 2003:
Antineuron antibodies and paraneoplastic neurological syndromes

Borsook, D.; Edwards, A.Davis., 2004:
Antineuropathic effects of the antibiotic derivative spicamycin KRN5500

Beacom, J.F.; Vagins, M.R., 2004:
Antineutrino spectroscopy with large water Cerenkov detectors

Mareen, P.; Van De Walle, S.; Bernaert, P.; Vanhouteghem, H.; Dierick, J., 2003:
Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis

Yang, G.; Tang, Z.; Chen, Y.; Zeng, C.; Chen, H.; Liu, Z.; Li, L., 2005:
Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis

Calvo-Romero, J.M.; Romero-Requena, J.; Arévalo-Lorido, J.C., 2003:
Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis

Malenica, B.; Rudolf, M.; Kozmar, A., 2004:
Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis

Bourreille, A.; Doubremelle, M.; Colombel, J-F., 2003:
Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease

Berlie, I.; Leboucher, B.; Leblanc, M.; Troussier, F.; Pellier, I.; Chevailler, A.; Giniès, J.L., 2005:
Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance

Manolova, I.; Dancheva, M., 2003:
Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis

Ayoub, Né.; Charuel, J-Luc.; Diemert, M-Claude.; Barete, Séphane.; André, M.; Fermand, J-Paul.; Piette, J-Charles.; Francès, C., 2004:
Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum

Attia, S.; Yalaoui, S.; Bousnina, S.; Fekih, L.; Hassen, H.; Fenniche, S.; Belhabib, D.; Mezni, F.; Megdiche, M., 2005:
Antineutrophil cytoplasmic antibodies positivity in a case of idiopathic pulmonary haemosiderosis

Wiesner, O.; Russell, K.A.; Lee, A.S.; Jenne, D.E.; Trimarchi, M.; Gregorini, G.; Specks, U., 2004:
Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis

Langford, C.A., 2005:
Antineutrophil cytoplasmic antibodies should not be used to guide treatment in Wegener's granulomatosis

Specks, U., 2005:
Antineutrophil cytoplasmic antibodies: are they pathogenic?

Bonaci-Nikolic, B.; Nikolic, M.M.; Andrejevic, S.; Zoric, S.; Bukilica, M., 2005:
Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides

Hidalgo V, S.; Silva A, P.; Undurraga S, F.; Soto I, Néstor.; Marinovic M, Mía.Angélica., 2006:
Antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis associated to the use of propylthiouracil. Report of four cases

Guo, X-hui.; Zhao, M-hui.; Gao, Y.; Wang, S-feng.; Gao, Y., 2003:
Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents

Yamauchi, K.; Sata, M.; Machiya, J-Ichi.; Osaka, D.; Wada, T.; Abe, S.; Otake, K.; Kubota, I., 2004:
Antineutrophil cytoplasmic antibody positive alveolar haemorrhage during propylthiouracil therapy for hyperthyroidism

Yoshida, M., 2003:
Antineutrophil cytoplasmic antibody(ANCA)

Chen, S-mei., 2005:
Antineutrophil cytoplasmic antibody-associated glomerulonephritis

Hung, P-Haur.; Chiang, W-Chih.; Chen, Y-Ming.; Lin, S-Liong.; Lin, W-Chou.; Tsai, T-Jun.; Chen, W-Yu., 2004:
Antineutrophil cytoplasmic antibody-associated glomerulonephritis in Taiwanese

Hirayama, K.; Koyama, A., 2005:
Antineutrophil cytoplasmic antibody-associated glomerulonephritis in type II diabetes mellitus

Doulton, T.W.R.; Tucker, B.; Reardon, J.; Velasco, N., 2004:
Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis

Coppo, P.; Ghez, D.; Fuentes, V.; Bengoufa, D.; Oksenhendler, E.; Tribout, B.; Clauvel, J-Pierre.; Lassoued, K., 2004:
Antineutrophil cytoplasmic antibody-associated neutropenia

Hsieh, H-Shin.; Chang, C-Fu.; Yang, A-Han.; Kuo, H-Ling.; Yang, W-Chang.; Lin, C-Ching., 2004:
Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report

Kamen, D.L.; Wigley, F.M.; Brown, A.N., 2006:
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis

Sheen, Y-Shuan.; Chu, C-Yu.; Yu, H-Su., 2006:
Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy

Kiliç, Z.Mesut.Yalin.; Tunç, B.; Ayaz, S.; Filik, L.; Aktaş, S.; Parlak, E.; Ulker, A., 2005:
Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases

Huugen, D.; Tervaert, J.Willem.Cohen.; Heeringa, P., 2003:
Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models

Chen, M.; Zhao, M-Hui.; Zhang, Y-Kang.; Wang, H-Yan., 2005:
Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules

Deutsch, M.; Guejes, L.; Zurgil, N.; Shovman, O.; Gilburd, B.; Afrimzon, E.; Shoenfeld, Y., 2005:
Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis

Zhang, J-jing.; Chen, Y-nan.; Xiao, H-jie.; Liu, J-cheng.; Yang, J-yun., 2004:
Antineutrophil cytoplasmic autoantibody positive vasculitis induced by propylthiouracil: a case report

Kallenberg, C.Gm., 2006:
Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis

Stöllberger, C.; Finsterer, J.; Zlabinger, G.J.; Weihsengruber, F.; Redtenbacher, S.; Bonner, G.; Herkner, K.; Deutsch, M., 2003:
Antineutrophil cytoplasmic autoantibody-negative antiproteinase 3 syndrome presenting as vasculitis, endocarditis, polyneuropathy and Dupuytren's contracture

Gatti, D.; Adami, S.; Canesi, B.; Cimmino, M.A.; Della Casa, O.; Del Tacca, M.; Klersy, C.; Leardini, G.; Patrignani, P.; Punzi, L.; Bombardieri, S., 2006:
Antinflammatory therapy and cardiovascular risk: a consensus view

Foulhoux, N., 1958:
Antinicotinic action of an oxime

Hazard, R.; Savini, E., 1952:
Antinicotinic action of the magnesium ion

Renier-Cornec, A., 1953:
Antinicotinic action on the isolated rat intestine of some local anesthetics

Reuse, J.J., 1952:
Antinicotinic properties of certain thiodiphenylamine derivatives

Villarreal, C.F.; Kina, V.Aparecida.V.; Prado, W.A., 2004:
Antinociception induced by stimulating the anterior pretectal nucleus in two models of pain in rats

Spengler, R.N.; Sud, R.; Knight, P.R.; Ignatowski, T.A., 2006:
Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release

Sasaki, M.; Obata, H.; Saito, S.; Goto, F., 2003:
Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain

Singh, A.; Kumar, G.; Naidu, P.S.; Kulkarni, S.K., 2004:
Antinociceptive action of FK506 in mice

Gupta, R.K.; Tandon, V.R., 2005:
Antinociceptive activity of Vitex-negundo Linn leaf extract

Bukhari, I.A.; Dar, A.; Khan, R.Alam., 2006:
Antinociceptive activity of methanolic extracts of St. John's Wort (Hypericum perforatum) preparation

Sztanke, K.; Fidecka, S.; Kedzierska, E.; Karczmarzyk, Z.; Pihlaja, K.; Matosiuk, D., 2005:
Antinociceptive activity of new imidazolidine carbonyl derivatives. Part 4. Synthesis and pharmacological activity of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c] [1,2,4]triazines

Biswal, S.; Das, M.Charana.; Nayak, P., 2004:
Antinociceptive activity of seeds of Trigonella foenum gracecum in rats

LaBuda, C.J.; Koblish, M.; Tuthill, P.; Dolle, R.E.; Little, P.J., 2005:
Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain

Suárez, Aírica.I.; Compagnone, R.S.; Salazar-Bookaman, M.M.; Tillett, S.; Delle Monache, F.; Di Giulio, C.; Bruges, G., 2003:
Antinociceptive and anti-inflammatory effects of Croton malambo bark aqueous extract

Korkmaz, H.Ayben.; Maltepe, F.; Erbayraktar, S.; Yilmaz, O.; Güray, M.; Canda, M.Serefettin.; Günerli, A.; Gökmen, N., 2003:
Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat

Baek, Y.Hyeon.; Huh, J.Eun.; Lee, J.Dong.; Choi, D.Young.; Park, D.Suk., 2006:
Antinociceptive effect and the mechanism of bee venom acupuncture (Apipuncture) on inflammatory pain in the rat model of collagen-induced arthritis: Mediation by alpha2-Adrenoceptors

Deraniyagala, S.A.; Ratnasooriya, W.D.; Goonasekara, C.L., 2003:
Antinociceptive effect and toxicological study of the aqueous bark extract of Barringtonia racemosa on rats

Berrino, L.; Oliva, P.; Massimo, F.; Aurilio, C.; Maione, S.; Grella, A.; Rossi, F., 2003:
Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test

Runfola, M.; Di Mugno, M.; Balletta, A.; Magalini, S.C.; Gui, D., 2006:
Antinociceptive effect of botulinum toxin: an added value to chemical sphincterotomy in anal fissure?

Murakami, M.; Nakagawasai, O.; Suzuki, T.; Mobarakeh, I.I.; Sakurada, Y.; Murata, A.; Yamadera, F.; Miyoshi, I.; Yanai, K.; Tan-No, K.; Sasano, H.; Tadano, T.; Iijima, T., 2004:
Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice

Rykaczewska-Czerwińska, M., 2007:
Antinociceptive effect of lidocaine in rats

Muneshige, H.; Toda, K.; Ma, D.; Kimura, H.; Asou, T.; Ikuta, Y., 2006:
Antinociceptive effect of linear polarized 0.6 to 1.6 microm irradiation of lumbar sympathetic ganglia in chronic constriction injury rats

Deciga-Campos, M.; González-Trujano, E.; Navarrete, Aés.; Mata, R., 2006:
Antinociceptive effect of selected Mexican traditional medicinal species

Khodayar, M.Javad.; Shafaghi, B.; Naderi, N.; Zarrindast, M-Reza., 2005:
Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions

Bhattacharjee, M.; Mathur, R., 2006:
Antinociceptive effect of sucrose ingestion in the human

Gupta, Y.K.; Sharma, M.; Briyal, S., 2005:
Antinociceptive effect of trans-resveratrol in rats: Involvement of an opioidergic mechanism

Kobashi, S.; Takizawa, M.; Kubo, H.; Yamauchi, T.; Higashiyama, K., 2003:
Antinociceptive effects of N-acyloctahydropyrido[3,2,1-ij][1,6]naphthyridine in mice: structure-activity relation study of matrine-type alkaloids part II

Buritova, J.; Le Guen, Séphanie.; Fournié-Zaluski, M-Claude.; Roques, B.P.; Besson, J-Marie., 2003:
Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord

Kesim, M.; Duman, E.N.; Kadioglu, M.; Ulku, C.; Muci, E.; Kalyoncu, N.I.; Yaris, E., 2006:
Antinociceptive effects of fluoxetine and paroxetine with their related actions on glycemia in mice

Masaki, E., 2006:
Antinociceptive effects of landiolol and esmolol

Amaral, P.de.Aguiar.; Bergold, A.Marie.; Eifler-Lima, V.Lucia.; Santos, E.Melo.dos.; Oliveira, E.Rolim.de.; Campos-Buzzi, Fátima.; Cechinel-Filho, V., 2005:
Antinociceptive effects of some synthetic delta-valerolactones

Parker, A.Garcia.; Peraza, G.Goulart.; Sena, J.; Silva, E.Sinnott.; Soares, M.Cristina.Flores.; Vaz, M.Regina.Cezar.; Furlong, E.Badiale.; Muccillo-Baisch, A.Luiza., 2006:
Antinociceptive effects of the aqueous extract of Brugmansia suaveolens flowers in mice

Otsuka, N.; Kiuchi, Y.; Yokogawa, F.; Masuda, Y.; Oguchi, K.; Hosoyamada, A., 2003:
Antinociceptive efficacy of antidepressants: assessment of five antidepressants and four monoamine receptors in rats

Beyreuther, B.; Callizot, Nëlle.; Stöhr, T., 2007:
Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain

Bonnefont, Jérôme.; Courade, J-Philippe.; Alloui, A.; Eschalier, A., 2004:
Antinociceptive mechanism of action of paracetamol

Tang, L.; Chen, Y.; Chen, Z.; Blumberg, P.M.; Kozikowski, A.P.; Wang, Z.Jim., 2007:
Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor

Porreca, F.; Vanderah, T.W.; Guo, W.; Barth, M.; Dodey, P.; Peyrou, V.; Luccarini, J.M.; Junien, J-L.; Pruneau, D., 2006:
Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist

McGaraughty, S.; Jarvis, M.F., 2006 :
Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist

Pertovaara, A., 2004:
Antinociceptive properties of fadolmidine (MPV-2426), a novel alpha2-adrenoceptor agonist

Otuki, M.F.; Ferreira, J.; Lima, F.V.; Meyre-Silva, C.; Malheiros, A.; Muller, L.A.; Cani, G.S.; Santos, A.R.S.; Yunes, R.A.; Calixto, Jão.B., 2005:
Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways

Pietrovski, E.F.; Rosa, K.A.; Facundo, V.A.; Rios, K.; Marques, M.Consuelo.A.; Santos, A.R.S., 2006:
Antinociceptive properties of the ethanolic extract and of the triterpene 3beta,6beta,16beta-trihidroxilup-20(29)-ene obtained from the flowers of Combretum leprosum in mice

Liang, L.Xin.; Zhang, Q.; Qian, W.; Hou, X.Hua., 2005:
Antinociceptive property of tegaserod in a rat model of chronic visceral hypersensitivity

Caram-Salas, N.L.; Medina-Santillán, R.; Reyes-García, G.; Granados-Soto, V., 2005:
Antinociceptive synergy between dexamethasone and the B vitamin complex in a neuropathic pain model in the rat

Ojewole, J.A.O., 2005:
Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm ['African Potato'] aqueous extract in mice and rats

Fang, H-Tao.; Huang, D-Shuang.; Wu, Y-Hua., 2005:
Antinoise approximation of the lidar signal with wavelet neural networks

Spielmann, A.C.; Spielmann, A., 2005:
Antinomic horizontal deviations: esodeviation associated with exodeviation. Clinical features and surgery

Thomas, B.L. , 1986:
Antinomy: the use, rights and regulation of laboratory animals

Belani, C.P., 2003:
Antinsense oligonucleotides in lung cancer: do they really make sense?

Westra, R.; Jansen, T.L.Th.A.; Gouw, A.S.H.; de Jong, K.P., 2003:
Antinucleair antibody (ANA) positivity caused by paraneoplastic antibodies due to abundant p53 expression in early hepatic carcinoma

Meyerzum Bueschenfelde, 1964:
Antinuclear Antibodies and Diseases of the Lymphoreticular System

Siegel, D.M., 2003:
Antinuclear Antibody (ANA) Testing

Faber, V.; Elling, P., 1964:
Antinuclear Factor (Anf). a new Serological Reaction

Zitnan, D., 1964:
Antinuclear Factors and their Relation to the Activity and Aggression of Systemic Lupus Erythematosus

Mazzei, D.; Luporini, G.; Sergiodelgiacco, G., 1964:
Antinuclear Factors in Collagen Diseases

Solheim, B.G., 1963:
Antinuclear Factors--Demonstration Using Fluorescent Antibodies

Straube, A.; Padovan, C.S.; Förderreuther, S.; Wick, M., 2003:
Antinuclear and anticardiolipin antibodies in primary headache syndromes

Yee, L.J.; Kelleher, P.; Goldin, R.D.; Marshall, S.; Thomas, H.C.; Alberti, A.; Chiaramonte, M.; Braconier, J-H.; Hall, A.J.; Thursz, M.R., 2004 :
Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance

Spiewak, R.; Stojek, N., 2003:
Antinuclear antibodies among eastern-Polish rural inhabitants

Dias, J.A.; de Oliveira, R.M.; Abrao, M.S., 2006:
Antinuclear antibodies and endometriosis

Holman, H.; Kunkel, H., 1959:
Antinuclear antibodies and their detection in systemic lupus erythematosus (SLE)

Spiewak, Rław.; Stojek, N.Maria.; Chmielewska-Badora, J., 2004:
Antinuclear antibodies are not increased in the early phase of Borrelia infection

De Rycke, L.; Kruithof, E.; Van Damme, N.; Hoffman, I.E.A.; Van den Bossche, N.; Van den Bosch, F.; Veys, E.M.; De Keyser, F., 2003:
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy

Gershwin, L.J., 2005:
Antinuclear antibodies in domestic animals

Ramírez-Sandoval, R.; Sánchez-Rodríguez, S.H.; Herrera-van Oostdam, D.; Avalos-Díaz, E.; Herrera-Esparza, R., 2003:
Antinuclear antibodies recognize cellular autoantigens driven by apoptosis

Win, T.; Groves, A.M.; Phillips, G.D., 2003:
Antinuclear antibody positive pleural effusion in a patient with tuberculosis

Afman, I.E.; Cronjé, H.S.; Joubert, G.; Badenhorst, P.N.; Schoon, M.G., 2004:
Antinuclear antibody testing in obstetric patients

Bossuyt, X.; Hendrickx, A.; Frans, J., 2005:
Antinuclear antibody titer and antibodies to extractable nuclear antigens

Cross, L.S.; Aslam, A.; Misbah, S.A., 2004:
Antinuclear antibody-negative lupus as a distinct diagnostic entity--does it no longer exist?

Mandema, E.; Pollak, V.E.; Kark, R.M., 1962:
Antinuclear factors and the protein spectrum in disseminated lupus erythematosus

Pollak, V.E.; Mandema, E.; Kark, R.M., 1960:
Antinuclear factors in the serum of relatives of patients with systemic lupus erythematosus

Hoxha, A.; Ruffatti, A.; Grypiotis, P.; Podswiadek, M.; Botsios, C.; Fiocco, U.; Punzi, L.; Todesco, S., 2006:
Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab

Cairns, A.P.; McMillan, S.A.; Crockard, A.D.; Meenagh, G.K.; Duffy, E.M.; Armstrong, D.J.; Bell, A.L., 2003:
Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus

Carratù, M.R.; Cassano, T.; Coluccia, A.; Borracci, P.; Cuomo, V., 2003:
Antinutritional effects of fumonisin B1 and pathophysiological consequences

Hatahet, M.Ammar.; Dhurandhar, N.V., 2003:
Antiobesity drugs: current and future issues

Hildebrandt, A.L.; Kelly-Sullivan, D.M.; Black, S.C., 2003:
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

Das, S.Kumar.; Chakrabarti, R., 2006:
Antiobesity therapy: emerging drugs and targets

Rosenzweig-Lipson, S.; Zhang, J.; Mazandarani, H.; Harrison, B.L.; Sabb, A.; Sabalski, J.; Stack, G.; Welmaker, G.; Barrett, J.E.; Dunlop, J., 2006:
Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503

Kokhanovskaia, T.M.; Popova, G.O., 1963:
Antiobiograms of Typhoid Bacilli. Ii. the Combined Action of Antibiotics on Freshly Isolated Typhoid Bacillus Strains

Rubensohn, M., 2005:
Antiobiotic responsive neuromuscular (cerebral) ataxia

Mardones, E.; Iglesias, R.; Lipschutz, A., 1954:
Antioestrogenic potencies of various progesterone derivatives with oxidation at C11

Zambelli, E.; Campi, L., 1954:
Antioncotic effect of radiophosphorus; studies on sarcoma in Galliera rats

de MAGALHAES, 1958:
Antiophidian campaign in Minas Gerais

Bocheva, A.; Dzambazova-Maximova, E., 2005:
Antiopioid properties of the TYR-MIF-1 family

Yarullin, K.K.; Vasilyeva, T.D.; Alekseev, D.A., 1976:
Antiorthostatic test as a model to study antigravity mechanisms of the cardiovascular system

Ottaviani, C., 1963:
Antiosteomyelitic rabbit serum. Immunoelectrophoretic study

Demary, W., 2006:
Antiosteoporosis medication: useful monitoring, and how long should such treatment be continued?

Reddy, N.Prabhakara.; Lakshmana, M.; Udupa, U.Venkatesh., 2004:
Antiosteoporotic activity of OST-6(Osteocare), a herbomineral preparation in calcium deficient ovariectomized rats

Shirwaikar, A.; Khan, S.; Malini, S., 2003:
Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat

Greenblatt, R.B., 1961:
Antiovulatory drugs and indications for their use

Franceschini, S.; Ceci, P.; Alaleona, F.; Chiancone, E.; Ilari, A., 2006:
Antioxidant Dps protein from the thermophilic cyanobacterium Thermosynechococcus elongatus

Odigie, I.P.; Okpoko, F.B.; Ojobo, P.D., 2007:
Antioxidant Effects of Vitamins C and E on Phenylhydrazine-Induced Haemolysis in Sprague Dawley Rats: Evidence for A better Protection by Vitamin E

Yang, L-Yo.; Ko, W-Chang.; Lin, C-Mao.; Lin, J-Wei.; Wu, J-Chine.; Lin, C-Ju.; Cheng, H-Hwa.; Shih, C-Ming., 2005:
Antioxidant N-acetylcysteine blocks nerve growth factor-induced H2O2/ERK signaling in PC12 cells

Safiulina, V.F.; Bikbulatova, L.S.; Mel'nik, A.I.; Skorinkin, A.I.; Basyan, A.S., 2006:
Antioxidant N-acetylcysteine modifies the purinergic modulation of spontaneous postsynaptic potentials in the newborn rat hippocampus

Hitooks, Y.; Sunagawa, K., 2006:
Antioxidant action and sympatho-inhibitory effect of ARB

Volotovskaia, A.V.; Ulashchik, V.S.; Filipovich, V.N., 2003:
Antioxidant action and therapeutic efficacy of laser irradiation of blood in patients with ischemic heart disease

Esumi, K.; Houdatsu, H.; Yoshimura, T., 2005:
Antioxidant action by gold-PAMAM dendrimer nanocomposites

Yoshida, Y.; Noguchi, N.; Watanabe, A.; Iwaki, Y.; Yanagisawa, M.; Kodama, T.; Cynshi, O.; Niki, E., 2003:
Antioxidant action of 2,2,4,6-tetra-substituted 2,3-dihydro-5-hydroxybenzofuran against lipid peroxidation: effects of substituents and side chain

Sprygin, V.G.; Kushnerova, N.F.; Rakhmanin, I.A., 2003:
Antioxidant action of oligomeric proanthocyanidins isolated from viburnum in liver lesions by carbon tetrachloride and prevention of the latter's toxicity

Khullar, M.; Relan, V.; Sehrawat, B.Singh.; Sherawat, B.S., 2004:
Antioxidant activities and oxidative stress byproducts in human hypertension

Stocker, R., 2004:
Antioxidant activities of bile pigments

Sugita, O.; Ishizawa, N.; Nakano, M.; Matsuto, T.; Okada, M., 2003:
Antioxidant activities of green and black teas determined by the cumene hydroperoxide/hemoglobin.methylene blue method

Noda, Y.; Ogata, K.; Mori, A., 2005:
Antioxidant activities of novel alpha-lipoic acid derivatives: N-(6, 8-dimercaptooctanoyl)-2-aminoethanesulfonate- and N-(6, 8-dimercaptooctanoyl)-L-aspartate-zinc complex

Yang, W-Min.; Liu, J-Kai.; Qin, X-Dong.; Wu, W-Lin.; Chen, Z-He., 2005:
Antioxidant activities of three dihydrochalcone glucosides from leaves of Lithocarpus pachyphyllus

Yuan, H.; Song, J.; Zhang, W.; Li, X.; Li, N.; Gao, X., 2005:
Antioxidant activity and cytoprotective effect of kappa-carrageenan oligosaccharides and their different derivatives

Ohnishi, M.; Matuo, T.; Tsuno, T.; Hosoda, A.; Nomura, E.; Taniguchi, H.; Sasaki, H.; Morishita, H., 2005:
Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice

Kerem, Z.; Bilkis, I.; Flaishman, M.A.; Sivan, L., 2006:
Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L

Lee, E-Jung.; Jang, H-Dong., 2005:
Antioxidant activity and protective effect on DNA strand scission of Rooibos tea (Aspalathus linearis)

Wang, S.Y.; Feng, R.; Bowman, L.; Penhallegon, R.; Ding, M.; Lu, Y., 2005:
Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation

Safitri, R.; Tarigan, P.; Freisleben, H.Joachim.; Rumampuk, R.J.; Murakami, A., 2004:
Antioxidant activity in vitro of two aromatic compounds from Caesalpinia sappan L

Resmi, C.R.; Venukumar, M.R.; Latha, M.S., 2006:
Antioxidant activity of Albizzia lebbeck (Linn.) Benth. in alloxan diabetic rats

Kumaran, A.; Karunakaran, R.Joel., 2006:
Antioxidant activity of Cassia auriculata flowers

Balaraman, R.; Bafna, P.A.; Kolhapure, S.A., 2004:
Antioxidant activity of DHC-1--a herbal formulation

Olek, R.Antoni.; Ziolkowski, W.; Kaczor, J.Jacek.; Greci, L.; Popinigis, J.; Antosiewicz, J., 2004:
Antioxidant activity of NADH and its analogue--an in vitro study

Ilavarasan, R.; Vasudevan, M.; Anbazhagan, S.; Venkataraman, S., 2003:
Antioxidant activity of Thespesia populnea bark extracts against carbon tetrachloride-induced liver injury in rats

Markaryan, A.A.; Dargaeva, T.D.; Mondodoev, A.G., 2004:
Antioxidant activity of a new dry plant extract nephrophyt

Campo, G.M.; Avenoso, A.; Campo, S.; Ferlazzo, A.M.; Calatroni, A., 2007:
Antioxidant activity of chondroitin sulfate

Amorati, R.; Lucarini, M.; Mugnaini, V.; Pedulli, G.Franco.; Roberti, M.; Pizzirani, D., 2004:
Antioxidant activity of hydroxystilbene derivatives in homogeneous solution

Klebanov, G.I.; Liubitskiĭ, O.B.; Il'ina, S.E.; Medusheva, E.O.; Ryl'tsev, V.V.; Filatov, V.N., 2006:
Antioxidant activity of inhibitors of free radical reactions in the dressing materials for wound healing

Karlsson, J.Olof.G., 2004:
Antioxidant activity of mangafodipir is not a new finding

Suslina, Z.A.; Fedorova, T.N.; Maksimova, M.Iu.; Kim, E.K., 2003:
Antioxidant activity of mildronate and L-carnitine in the treatment of patients with cerebrovascular diseases

Quevedo, W.C.; Isherwood, J.E., 1960:
Antioxidant activity of mouse liver and kidney extracts

de Groot, A.A.; Mathy, M-Jeanne.; van Zwieten, P.A.; Peters, S.L.M., 2003:
Antioxidant activity of nebivolol in the rat aorta

Roche, M.; Dufour, C.; Mora, N.; Dangles, O., 2005 :
Antioxidant activity of olive phenols: mechanistic investigation and characterization of oxidation products by mass spectrometry

Giacomelli, C.; Miranda, F.da.Silva.; Gonçalves, N.Sanches.; Spinelli, A., 2004:
Antioxidant activity of phenolic and related compounds: a density functional theory study on the O-H bond dissociation enthalpy

Ovesná, Z.; Kozics, Kína.; Bader, Y.; Saiko, P.; Handler, N.; Erker, T.; Szekeres, T., 2006:
Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines

Kelawala, N.S.; Ananthanarayan, L., 2005:
Antioxidant activity of selected foodstuffs

Andreassi, M.; Stanghellini, E.; Ettorre, A.; Di Stefano, A.; Andreassi, L., 2003:
Antioxidant activity of topically applied lycopene

Elmastaş, M.; Turkekul, I.; Oztürk, L.; Gülçin, I.; Isildak, O.; Aboul-Enein, H.Y., 2006:
Antioxidant activity of two wild edible mushrooms (Morchella vulgaris and Morchella esculanta) from North Turkey

Liyanapathirana, C.; Shahidi, F., 2005:
Antioxidant activity of wheat extracts as affected by in vitro digestion

Briganti, S.; Picardo, M., 2004:
Antioxidant activity, lipid peroxidation and skin diseases. What's new

Kim, H.Jong.; Chang, E-Ju.; Kim, H-Man.; Lee, S.Bok.; Kim, H-Duck.; Su Kim, G.; Kim, H-Hee., 2006:
Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha

Kotake, Y.; Moore, D.R.; Vasquez-Walden, A.; Tabatabaie, T.; Sang, H., 2003:
Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production

Kondo, K.; Yoneya, T., 2004:
Antioxidant and anti-allergic effects of polyphenols

Shibata, S.; Natori, Y.; Nishihara, T.; Tomisaka, K.; Matsumoto, K.; Sansawa, H.; Nguyen, V.Chuyen., 2004:
Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes

Farombi, E.O.; Ogundipe, O.; Moody, J.O., 2003:
Antioxidant and anti-inflammatory activities of Mallotus oppositifolium in model systems

Pontiki, E.; Hadjipavlou-Litina, D., 2006:
Antioxidant and anti-inflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors

He, Y-hui.; Xiao, C.; Wang, Y-sheng.; Zhao, L-hua.; Zhao, H-yan.; Tong, Y.; Zhou, J.; Jia, H-wei.; Lu, C.; Li, X-ming.; Lu, A-ping., 2006:
Antioxidant and anti-inflammatory effects of cyanidin from cherries on rat adjuvant-induced arthritis

Lu, G.; Shimizu, I.; Cui, X.; Itonaga, M.; Tamaki, K.; Fukuno, H.; Inoue, H.; Honda, H.; Ito, S., 2003:
Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats

Ju, E.Mi.; Lee, S.Eun.; Hwang, H.Jin.; Kim, J.Hee., 2003:
Antioxidant and anticancer activity of extract from Betula platyphylla var. japonica

Kraĭnova, T.A.; Efremova, L.M.; Mukhina, I.V.; Anastasiev, V.V., 2003:
Antioxidant and antihypoxic effects of the ceruloplasmin preparation in the hypobaric hypoxia model

Calò, L.A.; Semplicini, A.; Davis, P.A., 2005 :
Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients

Ozgen, U.; Houghton, P.J.; Ogundipe, Y.; Coşkun, M., 2003:
Antioxidant and antimicrobial activities of Onosma argentatum and Rubia peregrina

Krizková, Lívia.; Zitnanová, I.; Mislovicová, D.; Masárová, J.; Sasinková, V.; Duracková, Z.; Krajcovic, J., 2006:
Antioxidant and antimutagenic activity of mannan neoglycoconjugates: mannan-human serum albumin and mannan-penicillin G acylase

Nimptsch, J.; Wunderlin, D.A.; Dollan, A.; Pflugmacher, S., 2005:
Antioxidant and biotransformation enzymes in Myriophyllum quitense as biomarkers of heavy metal exposure and eutrophication in Suquía River basin (Córdoba, Argentina)

García-Alonso, Mía.; Rimbach, G.; Rivas-Gonzalo, Ján.C.; De Pascual-Teresa, S., 2004:
Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A--studies in platelets, monocytes, and human endothelial cells

Mor, M.; Spadoni, G.; Diamantini, G.; Bedini, A.; Tarzia, G.; Silva, C.; Vacondio, F.; Rivara, M.; Plazzi, P.Vincenzo.; Franceschini, D.; Zusso, M.; Giusti, P., 2004:
Antioxidant and cytoprotective activity of indole derivatives related to melatonin

Mathers, J.; Fraser, J.A.; McMahon, M.; Saunders, R.D.C.; Hayes, J.D.; McLellan, L.I., 2005:
Antioxidant and cytoprotective responses to redox stress

Mohamed, A-Fattah.; Ali Hasan, A.Gafar.; Hamamy, M.Ismail.; Abdel-Sattar, E., 2005:
Antioxidant and hepatoprotective effects of Eucalyptus maculata

Mary, N.K.; Shylesh, B.S.; Babu, B.H.; Padikkala, J., 2003:
Antioxidant and hypolipidaemic activity of a herbal formulation--liposem

Mikhaeil, B.R.; Badria, F.A.; Maatooq, G.T.; Amer, M.M.A., 2005:
Antioxidant and immunomodulatory constituents of henna leaves

Higashi-Okai, K.; Nagino, H.; Yamada, K.; Okai, Y., 2007:
Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation

Azam, S.; Hadi, N.; Khan, N.Uddin.; Hadi, S.Mumtaz., 2003:
Antioxidant and prooxidant properties of caffeine, theobromine and xanthine

Dwivedi, C.; Agrawal, P.; Natarajan, K.; Sharma, H., 2005:
Antioxidant and protective effects of Amrit Nectar tablets on adriamycin- and cisplatin-induced toxicities

Wang, L-Zhong.; Li, S-Tong.; Wang, Y-Tian.; Wang, Z-Ping., 2007:
Antioxidant attenuates acute lung injury after cardiopulmonary bypass in rats

Czeczot, H.; Scibior, D.; Skrzycki, Mł.; Podsiad, Młgorzata., 2005:
Antioxidant barrier in patients with gastric cancer--preliminary study

Gentile, C.; Tesoriere, L.; Allegra, M.; Livrea, M.A.; D'Alessio, P., 2005:
Antioxidant betalains from cactus pear (Opuntia ficus-indica) inhibit endothelial ICAM-1 expression

Christou, K.; Moulas, A.N.; Pastaka, C.; Gourgoulianis, K.I., 2003:
Antioxidant capacity in obstructive sleep apnea patients

Kartvelishvili, T.; Abuladze, M.; Asatiani, N.; Akhvlediani, J.; Asanishvili, L.; Holman, H-Ying.N.; Sapojnikova, N., 2004:
Antioxidant capacity of cultured mammalian cells estimated by ESR method

Arts, M.J.T.J.; Haenen, G.R.M.M.; Voss, H-Peter.; Bast, A., 2003:
Antioxidant capacity of reaction products limits the applicability of the Trolox Equivalent Antioxidant Capacity (TEAC) assay

Fehér, János.; Lugasi, A., 2005:
Antioxidant characteristics of a newly developed vermouth wine

Sharma, H.S.; Drieu, K.; Westman, J., 2004:
Antioxidant compounds EGB-761 and BN-52021 attenuate brain edema formation and hemeoxygenase expression following hyperthermic brain injury in the rat

Luyten, C.R.; van Overveld, F.J.; De Backer, L.A.; Sadowska, A.M.; Rodrigus, I.E.; De Hert, S.G.; De Backer, W.A., 2005:
Antioxidant defence during cardiopulmonary bypass surgery

Leclercq, I.A., 2003:
Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?

Gouveia, G.R.; Marques, D.S.; Cruz, B.P.; Geracitano, L.A.; Nery, L.E.M.; Trindade, G.S., 2004:
Antioxidant defenses and DNA damage induced by UV-A and UV-B radiation in the crab Chasmagnathus granulata (Decapoda, Brachyura)

Cheng, M-Ling.; Ho, H-Yao.; Tseng, H-Chuan.; Lee, C-Hong.; Shih, L-Yung.; Chiu, D.Tsun-Yee., 2004:
Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of alpha-thalassaemia

Shinomiya, K.; Mizushige, K.; Fukunaga, M.; Masugata, H.; Ohmori, K.; Kohno, M.; Senda, S., 2004:
Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells

Yoshimoto, T.; Fukai, N.; Sato, R.; Sugiyama, T.; Ozawa, N.; Shichiri, M.; Hirata, Y., 2004:
Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells

Sardo, M.Adriana.; Campo, S.; Bonaiuto, M.; Bonaiuto, A.; Saitta, C.; Trimarchi, G.; Castaldo, M.; Bitto, A.; Cinquegrani, M.; Saitta, A., 2005:
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients

Alvarez-Ayuso, L.; Calero, P.; Granado, F.; Jorge, E.; Herrero, C.; Torralba, A.; Millán, I.; Santos, Mín.; Blanco, I.; Olmedilla, Bña.; Castillo-Olivares, Jé.Luis., 2003:
Antioxidant effect of gamma-tocopherol supplied by propofol preparations (Diprivan) during ischemia-reperfusion in experimental lung transplantation

Tomlinson, B.; Benzie, I.F.F., 2003:
Antioxidant effect of lercanidipine

Kouoh, F.; Gressier, B.; Dine, T.; Luyckx, M.; Brunet, C.; Ballester, L.; Cazin, J.Claude., 2003:
Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils--a potential antiatherosclerotic property of calcium antagonists?

Jin, Y-Shan.; Lee, M-Jae.; Han, W.; Heo, S-Il.; Sohn, S.In.; Wang, M-Hyeon., 2006:
Antioxidant effects and hepatoprotective activity of 2,5-dihydroxy-4,3'-di(beta-d-glucopyranosyloxy)-trans-stilbene from Morus bombycis Koidzumi roots on CCl4-induced liver damage

Oxenkrug, G., 2005:
Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications

Yoshida, Y.; Niki, E., 2003:
Antioxidant effects of alpha- and gamma-carboxyethyl-6-hydroxychromans

Aydemir, O.; Nazıroğlu, M.; Celebi, S.; Yılmaz, T.; Kükner, A.Şahap., 2004:
Antioxidant effects of alpha-, gamma- and succinate-tocopherols in guinea pig retina during ischemia-reperfusion injury

Jaxa-Chamiec, T.; Bednarz, Bław.; Drozdowska, D.; Gessek, J.; Gniot, J.; Janik, K.; Kawka-Urbanek, T.; Maciejewski, Pł.; Ogórek, Mł.; Szpajer, Mł., 2005:
Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial

Ide, N.; Lau, B.H.; Ryu, K.; Matsuura, H.; Itakura, Y., 2004:
Antioxidant effects of fructosyl arginine, a Maillard reaction product in aged garlic extract

Rahman, Z.A.; Soory, M., 2006:
Antioxidant effects of glutathione and IGF in a hyperglycaemic cell culture model of fibroblasts: some actions of advanced glycaemic end products (AGE) and nicotine

García-Fernández, Mía.; Castilla-Cortázar, I.; Díaz-Sanchez, Mías.; Navarro, Iñigo.; Puche, J.Enrique.; Castilla, A.; Casares, A.Díaz.; Clavijo, E.; González-Barón, S., 2005:
Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis

Guzmán, D.Calderón.; Ruiz, N.Labra.; Mejía, G.Barragán.; García, E.Hernández.; Vázquez, I.R.Espitia.; Del Angel, D.Santamaría.; Ramírez, A.Morales.; Olguín, H.Juárez., 2003:
Antioxidant effects of selenium in rat brain and the stimulating role of nitric oxide

Stoll, L.L.; McCormick, M.L.; Denning, G.M.; Weintraub, N.L., 2005:
Antioxidant effects of statins

Rodríguez-Martínez, E.; Rugerio-Vargas, Cón.; Rodríguez, A.I.; Borgonio-Pérez, G.; Rivas-Arancibia, S., 2004:
Antioxidant effects of taurine, vitamin C, and vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats

Ichikawa, M.; Ryu, K.; Yoshida, J.; Ide, N.; Yoshida, S.; Sasaoka, T.; Sumi, S-Ichiro., 2003:
Antioxidant effects of tetrahydro-beta-carboline derivatives identified in aged garlic extract

Biri, A.; Bozkurt, N.; Gunaydin, G.; Korucuoglu, U.; Durak, I.; Kavutcu, M., 2007:
Antioxidant enzyme activities and lipid peroxidation in preeclampsia

Ho, S.P.; Chan-Yeung, M.; Chow, K.K.M.; Ip, M.S.M.; Mak, J.C.W., 2005:
Antioxidant enzyme activities in healthy Chinese adults: influence of age, gender and smoking

Mariani, E.; Cornacchiola, V.; Polidori, M.C.; Mangialasche, F.; Malavolta, M.; Cecchetti, R.; Bastiani, P.; Baglioni, M.; Mocchegiani, E.; Mecocci, P., 2006:
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status: results from the Zincage Project

Wang, J.; Xie, P., 2007:
Antioxidant enzyme activities of Microcystis aeruginosa in response to nonylphenols and degradation of nonylphenols by M. aeruginosa

Zgallaï, H.; Dridi, B.; Tarchoun, N.; Steppe, K., 2005:
Antioxidant enzyme activity during low temperature storage of potato tuber

Stojiljković, V.; Todorović, A.; Kasapović, J.; Pejić, S.; Pajović, S.B., 2005:
Antioxidant enzyme activity in rat hippocampus after chronic and acute stress exposure

Atmaca, M.; Tezcan, E.; Kuloglu, M.; Ustundag, B.; Tunckol, H., 2004:
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment

Tumkiratiwong, P.; Tungtrongchitr, R.; Migasena, P.; Pongpaew, P.; Rojekittikhun, W.; Vudhivai, N.; Tungtrongchitr, A.; Phonrat, B.; Nuamtanong, S., 2004:
Antioxidant enzyme levels in the erythrocytes of riboflavin-deficient and Trichinella spiralis-infected rats

Klemens, J.J.; Meech, R.P.; Hughes, L.F.; Somani, S.; Campbell, K.C.M., 2003:
Antioxidant enzyme levels inversely covary with hearing loss after amikacin treatment

Jandrić-Balen, M.; Bozikov, V.; Bistrović, D.; Jandrić, I.; Bozikov, J.; Romić, Z.; Balen, I. , 2004:
Antioxidant enzymes activity in patients with peripheral vascular disease, with and without presence of diabetes mellitus

Kahl, R.; Kampkötter, A.; Wätjen, W.; Chovolou, Y., 2004:
Antioxidant enzymes and apoptosis

Dündarz, M.Ruşen.; Türkbay, Tümer.; Akay, C.; Sarici, S.Umit.; Aydin, A.; Denli, M.; Gökçay, E., 2003:
Antioxidant enzymes and lipid peroxidation in adolescents with inhalant abuse

Jyothi, M.; Sanil, R.; Sreekumar, R.; Shashidhar, S., 2004:
Antioxidant enzymes and peroxidation in galactogenic cataract

Stepnewski, M.; Kolarzyk, E.; Pietrzycka, A.; Kitlinski, M.; Helbin, J.; Brzyszczan, K., 2003:
Antioxidant enzymes and pulmonary function in steel mill welders

Casado, A.; de la Torre, R.; López-Fernández, M.E.; Gil, P.; Egido, J.A., 2004:
Antioxidant enzymes in acute cerebral infarction

Järvelä, S.; Sally, Järvelä.; Bragge, H.; Helena, B.; Paunu, N.; Niina, P.; Järvelä, T.; Timo, Järvelä.; Paljärvi, L.; Leo, Pärvi.; Kalimo, H.; Hannu, K.; Helén, P.; Pauli, Hén.; Kinnula, V.; Vuokko, K.; Soini, Y.; Ylermi, S.; Haapasalo, H.; Hannu, H., 2005:
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival

Aksoy, Y.; Sanal, O.; Metin, Aşe.; Tezcan, I.; Ersoy, Fügen.; Oğüş, H.; Ozer, N., 2004:
Antioxidant enzymes in red blood cells and lymphocytes of ataxia-telangiectasia patients

Soini, Y.; Kallio, J.P.; Hirvikoski, P.; Helin, H.; Kellokumpu-Lehtinen, P.; Tammela, T.L.J.; Peltoniemi, M.; Martikainen, P.M.; Kinnula, L.V., 2005:
Antioxidant enzymes in renal cell carcinoma

Mokhal'chik, E.V.; Titkova, S.M.; Anurov, M.V.; Pen'kov, L.Iu.; Korkina, L.G., 2007:
Antioxidant enzymes in skin experimental burn trauma

Venediktova, N.I.; Lopata, O.V.; Pogosian, A.S.; Kosenko, E.A.; Kaminskiĭ, I.G., 2005:
Antioxidant enzymes of the rat liver, brain, heart and erythrocytes in ammonia intoxication

Moragón, A.Casado.; De Lucas García, N.; Encarnación López Fernández, M.; Rodriguez-Manzaneque, A.Sánchez.; Jimenez Fraile, Jé.A., 2005:
Antioxidant enzymes, occupational stress and burnout in workers of a prehospitalary emergency service

Crozier, A.; Burns, J.; Aziz, A.A.; Stewart, A.J.; Rabiasz, H.S.; Jenkins, G.I.; Edwards, C.A.; Lean, M.E., 2005:
Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability

Morozova, N.; Forry, E.P.; Shahid, E.; Zavacki, A.Marie.; Harney, J.W.; Kraytsberg, Y.; Berry, M.J., 2004:
Antioxidant function of a novel selenoprotein in Drosophila melanogaster

Kawamoto, K.; Sha, S-Hua.; Minoda, R.; Izumikawa, M.; Kuriyama, H.; Schacht, J.; Raphael, Y., 2004:
Antioxidant gene therapy can protect hearing and hair cells from ototoxicity

Palasuwan, A.; Kittisakulrat, T.; Amornrit, W.; Soogarun, S.; Wiwanitkit, V.; Pradniwat, P., 2006:
Antioxidant in plasma of hemoglobin-E trait

Hyson, D.A., 2006:
Antioxidant intake and coronary atherosclerosis: consider a "foods first" approach

Daryani, A.; Basu, S.; Becker, W.; Larsson, A.; Risérus, U., 2006:
Antioxidant intake, oxidative stress and inflammation among immigrant women from the Middle East living in Sweden: associations with cardiovascular risk factors

Sajjad, Y.; Leonard, M.; Doyle, M., 2004:
Antioxidant levels in the cord blood of term fetus

Hashim, Z.; Zarina, S., 2006:
Antioxidant markers in human senile and diabetic cataractous lenses

Lukivskaya, O.; Zavodnik, L.; Knas, M.; Buko, V., 2007:
Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis

Murray, A.P.; Rodriguez, S.; Frontera, Mía.A.; Tomas, Mía.A.; Mulet, Mía.C., 2005:
Antioxidant metabolites from Limonium brasiliense (Boiss.) Kuntze

Nasr, M.R.; Ali, S.; Shaker, M.; Elgabry, E., 2004:
Antioxidant micronutrients in children with thalassaemia in Egypt

Tukalenko, I.V.; Varets'kyĭ, V.V.; Rakochi, O.H.; Dmytriieva, I.R.; Makarchuk, M.Iu., 2006:
Antioxidant modification of ionizing irradiation and additional stress effects on higher nervous activity in rats

Baldwin, C.M.; Bootzin, R.R.; Schwenke, D.C.; Quan, S.F., 2005:
Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea

Guruvayoorappan, C.; Afira, A.H.; Kuttan, G., 2007:
Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo

Kalra, N.; Prasad, S.; Shukla, Y., 2005:
Antioxidant potential of black tea against 7,12-dimethylbenz(a)anthracene- induced oxidative stress in Swiss albino mice

Zaidi, S.M.Kashif.R.; Banu, N., 2004 :
Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain

Mehdipour, S.; Yasa, N.; Dehghan, G.; Khorasani, R.; Mohammadirad, A.; Rahimi, R.; Abdollahi, M., 2006:
Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to alpha-tocopherol

Jung, M.Jung.; Chung, H.Young.; Choi, J.Ho.; Choi, J.Sue., 2003:
Antioxidant principles from the needles of red pine, Pinus densi fl ora

Siquet, C.; Paiva-Martins, Fátima.; Lima, Jé.L.F.C.; Reis, S.; Borges, F., 2006:
Antioxidant profile of dihydroxy- and trihydroxyphenolic acids--a structure-activity relationship study

Lee, Y-Shun.; Chou, Y-Hung., 2006:
Antioxidant profiles in full term and preterm neonates

Vogel, H.; González, M.; Faini, F.; Razmilic, Ián.; Rodríguez, J.; Martín, Jé.San.; Urbina, F., 2005:
Antioxidant properties and TLC characterization of four Chilean Haplopappus-species known as bailahuén

Schaffer, S.; Schmitt-Schillig, S.; Müller, W.E.; Eckert, G.P., 2005:
Antioxidant properties of Mediterranean food plant extracts: geographical differences

Caro, A.A.; Cederbaum, A.I., 2004:
Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations

Ipatova, O.M.; Prozorovskaia, N.N.; Rusina, I.F.; Prozorovskiĭ, V.N., 2003:
Antioxidant properties of a leaf extract from Aronia (Aronia melanocarba) containing proanthocyanidins

Radomska, A., 2003:
Antioxidant properties of captopril in vitro

Gregor, W.; Adelwöhrer, C.; Rosenau, T.; Grabner, G.; Gille, L., 2005:
Antioxidant properties of chromanols derived from vitamin E and ubiquinone

Vargas, F.; Rivas, C.; Díaz, Y.; Contreras, N.; Silva, A.; Ojeda, L.E.; Velásquez, M.; Fraile, G., 2003:
Antioxidant properties of dipyridamole as assessed by chemiluminescence

Misharina, T.A.; Polshkov, A.N., 2005:
Antioxidant properties of essential oils: autoxidation of essential oils from laurel and fennel and effects of mixing with essential oil from coriander

Masuda, Y.; Kikuzaki, H.; Hisamoto, M.; Nakatani, N., 2005:
Antioxidant properties of gingerol related compounds from ginger

Kayano, S-ichi.; Kikuzaki, H.; Yamada, N.Fukutsuka.; Aoki, A.; Kasamatsu, K.; Yamasaki, Y.; Ikami, T.; Suzuki, T.; Mitani, T.; Nakatani, N., 2005:
Antioxidant properties of prunes (Prunus domestica L.) and their constituents

Hrynevych, I.P.; Oliĭnyk, S.A.; Shtemenko, N.I.; Shtemenko, O.V., 2003:
Antioxidant properties of rhenium cluster complexes with butyric acid derivatives in blood plasma and erythrocytes

Herold, A.; Cremer, L.; Calugăru, A.; Tamaş, V.; Ionescu, F.; Manea, S.; Szegli, G., 2005:
Antioxidant properties of some hydroalcoholic plant extracts with antiinflammatory activity

Mavi, A.; Terzi, Z.; Ozgen, U.; Yildirim, A.; Coşkun, M., 2004:
Antioxidant properties of some medicinal plants: Prangos ferulacea (Apiaceae), Sedum sempervivoides (Crassulaceae), Malva neglecta (Malvaceae), Cruciata taurica (Rubiaceae), Rosa pimpinellifolia (Rosaceae), Galium verum subsp. verum (Rubiaceae), Urtica dioica (Urticaceae)

Drinitsina, S.V.; Zateĭshchikov, D.A., 2005:
Antioxidant properties of statins

McCarron, R.M.; Shohami, E.; Panikashvili, D.; Chen, Y.; Golech, S.; Strasser, A.; Mechoulam, R.; Spatz, M., 2004:
Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG)

Manikandan, S.; Devi, R.Sheela., 2005:
Antioxidant property of alpha-asarone against noise-stress-induced changes in different regions of rat brain

Castellani, R.J.; Lee, H-Gon.; Perry, G.; Smith, M.A., 2006:
Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau

Michos, C.; Kiortsis, D.N.; Evangelou, A.; Karkabounas, S., 2006:
Antioxidant protection during the menstrual cycle: the effects of estradiol on ascorbic-dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrhoic women during the menstrual cycle

Walsh, K.A.; Megyesi, J.F.; Wilson, J.X.; Crukley, J.; Laubach, V.E.; Hammond, R.R., 2004:
Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity

Ciuffi, M.; Pisanello, M.; Pagliai, G.; Raimondi, L.; Franchi-Micheli, S.; Cantore, M.; Mazzetti, L.; Failli, P., 2004:
Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure

Pobed'onna, H.P., 2006:
Antioxidant protection, metabolites of nitrogen oxide on the forming of oxidative stress in patients with bronchial asthma

Hanukoglu, I., 2006:
Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells

Liu, J.; Su, B.; Lagger, Gégoire.; Tacchini, P.; Girault, H.H., 2006:
Antioxidant redox sensors based on DNA modified carbon screen-printed electrodes

Anonymous, 1961:
Antioxidant replacements for vitamin E

Li, J.; Lee, J-Min.; Johnson, D.A.; Johnson, J.A., 2004:
Antioxidant responsive element activation by quinones: antioxidant responsive element target genes, role of PI3 kinase in activation

Jang, A-Soo.; Choi, I-S.; Yang, S-Yeul.; Kim, Y-Gon.; Lee, J-Hyuk.; Park, S-Woo.; Park, C-Sik., 2005:
Antioxidant responsiveness in BALB/c mice exposed to ozone

Sharma, R.; Yang, Y.; Sharma, A.; Awasthi, S.; Awasthi, Y.C., 2004:
Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis

Gonzales, S.; Perez, M-Julia.; Perazzo, J-C.; Tomaro, M-Lujan., 2006:
Antioxidant role of heme oxygenase-1 in prehepatic portal hypertensive rats

Hu, M-Lin.; Wang, R-Juh., 2004:
Antioxidant role of mulberry leaves in streptozotocin-diabetic rats

Todorović, T.; Dozić, I.; Mandić, B.; Marjanović, M., 2005:
Antioxidant role of saliva in maintaining oral health

Liu, J.; Roussel, C.; Lagger, Gégoire.; Tacchini, P.; Girault, H.H., 2005:
Antioxidant sensors based on DNA-modified electrodes

Shilina, N.M.; Koterov, A.N.; Zorin, S.N.; Kon, I.Ya., 2004:
Antioxidant spectrum of blood serum and its peculiarities in children

Karatas, F.; Ozates, I.; Canatan, H.; Halifeoglu, I.; Karatepe, M.; Colakt, R., 2004 :
Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis

Battino, M.; Bompadre, S.; Politi, A.; Fioroni, M.; Rubini, C.; Bullon, P., 2006:
Antioxidant status (CoQ10 and Vit. E levels) and immunohistochemical analysis of soft tissues in periodontal diseases

Bhaskar, A.; Jeyarani, A.; Merlin, M.N., 2006:
Antioxidant status and total peroxyl radical trapping antioxidant activity (TRAP) in cement workers

Zimmermann, C.; Winnefeld, K.; Streck, S.; Roskos, M.; Haberl, R.L., 2004:
Antioxidant status in acute stroke patients and patients at stroke risk

Yessoufou, A.; Moutairou, K.; Girard, A.; Fatoke, M.; Prost, J.; Ahissou, H.; Djrolo, F.; Avode, G.; Amoussou-Guenou, D.; Hichami, A.; Khan, N.A., 2005:
Antioxidant status in alcohol-related diabetes mellitus in Beninese subjects

Dhawan, V.; Kumar, K.Ratan.; Marwaha, R.K.; Ganguly, N.K., 2005:
Antioxidant status in children with homozygous thalassemia

Rokicki, Władysław.; Strzałkowski, A.; Kłapcińska, B.; Danch, A.; Sobczak, A., 2004:
Antioxidant status in newborns and infants suffering from congenital heart defects

Park, K.Sik.; Jang, B.Kuk.; Kwon, K.Min.; Chung, W.Jin.; Cho, K.Bum.; Hwang, J.Seok.; Ahn, S.Hoon.; Mun, K.Cheol.; Kim, Y.Hwan., 2005:
Antioxidant status in nonalcoholic steatohepatitis

Tsekhmistrenko, S.I.; Ponamarenko, N.V.; Chubar, O.M., 2006:
Antioxidant status in tissue of the liver and pancreas of quails and its correction by adding the corn of amaranth to their feed

Anetor, J.I.; Ajose, O.A.; Ige, O.; Oyeleye, A.O.; Ojo, P.O., 2004:
Antioxidant status of adult Nigerian asthmatics: implications for prognosis

Pogosyan, A.S.; Venediktova, N.I.; Kosenko, E.A.; Kaminskii, Y.G., 2004:
Antioxidant status of erythrocytes after acupuncture treatment

Borisenkov, M.F.; Efimtseva, E.A.; Chelpanova, T.I.; Tallina, V.A.; Bakutova, L.A., 2007:
Antioxidant status of ewe's blood during pregnancy and lactation

Pechan, I.; Olejarova, I.; Danova, K.; Fischer, V.; Minarova, H.; Dobisova, A.; Halcak, L.; Rendekova, V.; Gabauer, I., 2004:
Antioxidant status of patients after on-pump and off-pump coronary artery bypass grafting

Czeczot, H.; Skrzycki, Mł.; Podsiad, Młgorzata.; Gawryszewska, E.; Nyckowski, Pł.; Porembska, Z., 2005:
Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer

Kravchenko, L.V.; Morozov, S.V.; Beketova, N.A.; Deryagina, V.P.; Avren'eva, L.I.; Tutel'yan, V.A., 2003:
Antioxidant status of rats receiving lycopene in different doses

Shajil, E.M.; Begum, R., 2006:
Antioxidant status of segmental and non-segmental vitiligo

Aydin, S., 2006:
Antioxidant status, alpha-amylase production, growth, and survival of hemoglobin bearing Escherichia coli exposed to hypochlorous acid

Christofidou-Solomidou, M.; Muzykantov, V.R., 2006:
Antioxidant strategies in respiratory medicine

Vernet, P.; Aitken, R.J.; Drevet, J.R., 2004:
Antioxidant strategies in the epididymis

Shishehbor, M.H.; Hazen, S.L., 2004:
Antioxidant studies need a change of direction

Aro, A., 2005:
Antioxidant supplementation and risk of chronic disease

Lindheimer, M.D.; Sibai, B.M., 2006:
Antioxidant supplementation in pre-eclampsia

Czernichow, S.; Bertrais, S.; Blacher, J.; Galan, P.; Briançon, S.; Favier, A.; Safar, M.; Hercberg, S., 2006:
Antioxidant supplements and risk of hypertension in the SU.VI.MAX trial: relationship to plasma antioxidants

Hamilton, K.K., 2003:
Antioxidant supplements during cancer treatments: where do we stand?

Lirussi, F.; Azzalini, L.; Orando, S.; Orlando, R.; Angelico, F., 2007:
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis

Correa, P.; Fontham, E.; Bravo, L.E.; Mera, R., 2005:
Antioxidant supplements for prevention of gastrointestinal cancers

Moreno-Reyes, R.; Boelaert, M.; Meuris, S., 2005:
Antioxidant supplements for prevention of gastrointestinal cancers

Anonymous, 2003:
Antioxidant supplements may not help heart health

Anonymous, 2003:
Antioxidant supplements plus zinc may slow age-related macular degeneration

Anonymous, 2003:
Antioxidant supplements: bad news and good news

Gulevskiĭ, A.K.; Grishchenkova, E.A.; Relina, L.I., 2006:
Antioxidant system in the darkling beetle (Tenebrio molitor) in ontogenesis

Gorozhanskaia, E.G.; Davydova, T.V.; Zubrikhina, G.N.; Kormosh, N.G.; Laktionov, K.P., 2003:
Antioxidant system of platelets in patients with ovary cancer

Pluzhnikov, N.N.; Tiaptin, A.A.; Zemlianoĭ, A.V.; Varlashova, M.B.; Torkunov, P.A.; Lupachev, I.A., 2004:
Antioxidant system of the rat brain in toxic lung edema

Laperuta, A.M., 1958:
Antioxidant system; clinical experiment in tuberculosis; preliminary report

Rahman, I.; Kilty, I., 2006:
Antioxidant therapeutic targets in COPD

Hunninghake, G.W., 2005:
Antioxidant therapy for idiopathic pulmonary fibrosis

van der Merwe, J.; Leong, J-Yoong.; Kaye, D.; Opat, S.; Bergin, P.J.; Taylor, A.J.; Rosenfeldt, F., 2007:
Antioxidant therapy for severe cardiac failure induced by iron overload secondary to dyserythropoietic anaemia

Pinsky, M.R., 2003:
Antioxidant therapy for severe sepsis: promise and perspective

Lengyel, G.; Tulassay, Z., 2006:
Antioxidant therapy in chronic liver diseases

Magomedov, M.A., 2004:
Antioxidant therapy in combined treatment of postoperative intestinal paresis

Rotstein, O.D., 2004:
Antioxidant therapy in critical illness

Da Ros, R.; Assaloni, R.; Ceriello, A., 2004:
Antioxidant therapy in diabetic complications: what is new?

Wells, A.U., 2006:
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled

Lovat, R.; Preiser, J-Charles., 2003:
Antioxidant therapy in intensive care

Medina, Jús.; Moreno-Otero, R., 2006:
Antioxidant therapy in liver ischemia-reperfusion injury

Albuszies, G.; Brückner, U.Bernd., 2003:
Antioxidant therapy in sepsis

Gordon, C.A.; Himmelfarb, J., 2004:
Antioxidant therapy in uremia: evidence-based medicine?

Xia, Z.; Gu, J.; Ansley, D.M.; Xia, F.; Yu, J., 2003:
Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease

Henrotin, Y.; Kurz, B., 2007:
Antioxidant to treat osteoarthritis: dream or reality?

Bukan, N.; Güney, Y.; Hiçsönmez, Aşe.; Bilgihan, Aşe., 2004:
Antioxidant tolerance of kidney after irradiation

Simpson, E.P., 2005:
Antioxidant treatment for amyotrophic lateral sclerosis

Orrell, R.W.; Lane, R.J.M.; Ross, M., 2007:
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease

Ersoy, A., 2006:
Antioxidant treatment in dialysis patients- importance of ferritin

Caccamo, D.; Campisi, A.; Currò, M.; Bramanti, V.; Tringali, M.; Li Volti, G.; Vanella, A.; Ientile, R., 2005:
Antioxidant treatment inhibited glutamate-evoked NF-kappaB activation in primary astroglial cell cultures

Besse, S.; Bulteau, A.L.; Boucher, F.; Riou, B.; Swynghedauw, B.; de Leiris, J., 2007:
Antioxidant treatment prevents cardiac protein oxidation after ischemia-reperfusion and improves myocardial function and coronary perfusion in senescent hearts

Yusuf, M.Aslam.; Sarin, N.Bhalla., 2006:
Antioxidant value addition in human diets: genetic transformation of Brassica juncea with gamma-TMT gene for increased alpha-tocopherol content

Gu, W.; Shang, X.; Huang, Y., 2004:
Antioxidant vitamin and male reproduction

Hatzigeorgiou, C.; Taylor, A.J.; Feuerstein, I.M.; Bautista, L.; O'Malley, P.G., 2006:
Antioxidant vitamin intake and subclinical coronary atherosclerosis

Yuen, B.; Furrer, L.; Ballmer, P.E., 2005:
Antioxidant vitamin supplementation in the prevention of cardiovascular disease

Pasco, J.A.; Henry, M.J.; Wilkinson, L.K.; Nicholson, G.C.; Schneider, H.G.; Kotowicz, M.A., 2006:
Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women

Ruano-Ravina, A.; Figueiras, A.; Freire-Garabal, M.; Barros-Dios, J.M., 2006:
Antioxidant vitamins and risk of lung cancer

Hasanain, B.; Mooradian, A.D., 2003:
Antioxidant vitamins and their influence in diabetes mellitus

Anonymous, 2003:
Antioxidant vitamins and zinc for macular degeneration

Bednarz, Bław.; Chamiec, T.; Ceremuzyński, L., 2003:
Antioxidant vitamins decrease exercise-induced QT dispersion after myocardial infarction

Roychoudhury, P.; Schwartz, K., 2003:
Antioxidant vitamins do not prevent cardiovascular disease

Paolini, M.; Sapone, A.; Canistro, D.; Chieco, P.; Valgimigli, L., 2003:
Antioxidant vitamins for prevention of cardiovascular disease

Ahmed, J.; Zaman, M.M.; Ali, K., 2003:
Antioxidant vitamins improves hemoglobin level in children with group a beta hemolytic streptococcal infection

Biesalski, H.K.; Böhles, H.; Esterbauer, H.; Fürst, P.; Gey, F.; Hundsdörfer, G.; Kasper, H.; Sies, H.; Weisburger, J., 1997:
Antioxidant vitamins in prevention

Spirichev, V.B., 2004:
Antioxidant vitamins in the treatment and prevention of cardiovascular diseases. Vitamin E

Valachovicova, M.; Krajcovicova-Kudlackova, M.; Ginter, E.; Paukova, V., 2004:
Antioxidant vitamins levels--nutrition and smoking

Pachocka, L.M.; Bułhak-Jachymczyk, B.; Kłosiewicz-Latoszek, L.; Stolarska, I.; Grzybek, A.; Targosz, U., 2006:
Antioxidant vitamins status in patients with combined hyperlipidemia

Abdollahi, M.; Salehnia, A.; Mortazavi, S.Hamid.Reza.; Ebrahimi, M.; Shafiee, A.; Fouladian, F.; Keshavarz, K.; Sorouri, S.; Khorasani, R.; Kazemi, A., 2003:
Antioxidant, antidiabetic, antihyperlipidemic,reproduction stimulatory properties and safety of essential oil of Satureja Khuzestanica in rat in vivo: a oxicopharmacological study

Hong, J.; Lee, E.; Carter, J.C.; Masse, J.A.; Oksanen, D.A., 2004:
Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation

Wennig, F., 1958:
Antioxidants & liver insufficiency

Burckhardt, W.; Fierz, U., 1964:
Antioxidants in Margarine as the Cause of Occupational Eczemas

Gyoergy, P.; Murata, K.; Ikehata, H., 1964:
Antioxidants Isolated from Fermented Soybeans (Tempeh)

Khaldi, M.Z.; Elouil, H.; Guiot, Y.; Henquin, J.C.; Jonas, J.C., 2006:
Antioxidants N-acetyl-L-cysteine and manganese(III)tetrakis (4-benzoic acid)porphyrin do not prevent beta-cell dysfunction in rat islets cultured in high glucose for 1 wk

Dubovskiĭ, I.M.; Olifirenko, O.A.; Glupov, V.V., 2005:
Antioxidants activity in intestines of larvae Galleria mellonella L. (Lepidoptera, Pyralidae) during Bacillus thuringiensis ssp Galleriae infection

Edmund, C., 2006:
Antioxidants and AMD

Ames, D.; Ritchie, C., 2007:
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?

Rao, R.Jagdeeshwar.; Kumar, U.Sampath.; Reddy, S.Venkat.; Tiwari, A.K.; Rao, J.Madhusudana., 2005:
Antioxidants and a new germacrane sesquiteroene from Carissa spinarum

Laule, M.; Stangl, V.; Stangl, K., 2004:
Antioxidants and atherosclerosis. What is certain in primary and secondary prevention?

Tardif, J-Claude., 2005:
Antioxidants and atherosclerosis: emerging drug therapies

Ladas, E.J.; Jacobson, J.S.; Kennedy, D.D.; Teel, K.; Fleischauer, A.; Kelly, K.M., 2004:
Antioxidants and cancer therapy: a systematic review

Block, K.I., 2004:
Antioxidants and cancer therapy: furthering the debate

Morán, Mía.; Blázquez, I.; Saborido, A.; Megías, A., 2005:
Antioxidants and ecto-5'-nucleotidase are not involved in the training-induced cardioprotection against ischaemia-reperfusion injury

Skibsted, L.H.; Dragsted, L.O.; Dyerberg, Jørn.; Hansen, H.S.; Kiens, B.; Ovesen, L.F.; Tjønneland, A.M., 2006:
Antioxidants and health

Hasnis, E.; Reznick, A.Z., 2003:
Antioxidants and healthy aging

McInnes, G.T., 2005:
Antioxidants and hypertension: another false dawn?

Opara, E.C.; Rockway, S.W., 2006:
Antioxidants and micronutrients

Blomhoff, R., 2004:
Antioxidants and oxidative stress

Enoch, J., 2005:
Antioxidants and preeclampsia

Mathews, F.; Neil, A., 2005:
Antioxidants and preterm prelabour rupture of the membranes

Ritter, C.; Andrades, M.; Moreira, Jé.Cláudio.F.; Dal-Pizzol, F., 2004:
Antioxidants and sepsis: can we find the ideal approach?

Huber, R.; Schroeder, E., 1962:
Antioxidants and survival rate in total-body irradiated mice

Jeyabalan, A.; Caritis, S.N., 2006:
Antioxidants and the prevention of preeclampsia--unresolved issues

Sultanov, G.A.; Azimov, E.Kh.; Ibishov, K.G., 2005:
Antioxidants and their use in medical practice

Anonymous, 2004:
Antioxidants and thyroid disease. Proceedings of a meeting. June 6-7, 2003. Chania, Crete

Podratz, J.L.; Rodriguez, E.H.; Windebank, A.J., 2003:
Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro

Hajieva, P.; Behl, C., 2006:
Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease

Povarova, O.V.; Kalenikova, E.I.; Gorodetskaia, E.I.; Medvedev, O.S., 2003:
Antioxidants as neuroprotectors in ischemic stroke

Park, S.Ju.; Lee, Y.Chul., 2006:
Antioxidants as novel agents for asthma

Shults, C.W., 2005:
Antioxidants as therapy for Parkinson's disease

Leborgne, L.; Fournadjiev, J.; Pakala, R.; Dilcher, C.; Cheneau, E.; Wolfram, R.; Hellinga, D.; Seaborn, R.; O'Tio, F.; Waksman, R., 2003:
Antioxidants attenuate atherosclerotic plaque development in a balloon-denuded and -radiated hypercholesterolemic rabbit

Dhaunsi, G.S.; Bitar, M.S., 2004:
Antioxidants attenuate diabetes-induced activation of peroxisomal functions in the rat kidney

Hicks, J.J.; Montes-Cortes, D.H.; Cruz-Dominguez, M.P.; Medina-Santillan, R.; Olivares-Corichi, I.M., 2006:
Antioxidants decrease reperfusion induced arrhythmias in myocardial infarction with ST-elevation

Cerecetto, H.; López, G.V., 2007:
Antioxidants derived from vitamin E: an overview

Anonymous, 2006:
Antioxidants do not prevent colorectal cancer

Ernst, A.; Stolzing, A.; Sandig, G.; Grune, T., 2003:
Antioxidants effectively prevent oxidation-induced protein damage in OLN 93 cells

Burduk, Pł.Krzysztof.; Betlejewski, Sław.; Drewa, G., 2006:
Antioxidants enzymes activity and concentration of lipid peroxidation products in chronic tonsillitis before and after surgery

Fuchs, G.J., 2005:
Antioxidants for children with kwashiorkor

Connors, N.; Merrill, D., 2004:
Antioxidants for prevention of preterm delivery

Dugo, G.; Salvo, F.; Dugo, P.; La Torre, G.L.; Mondello, L., 2004:
Antioxidants in Sicilian wines: analytic and compositive aspects

Prasad, K.N., 2003:
Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies

Prasad, K.N.; Cole, W.C., 2006:
Antioxidants in cancer therapy

Lankin, V.Z.; Tikhaze, A.K.; Belenkov, I.N., 2004:
Antioxidants in complex therapy of atherosclerosis: pro et contra

Andreassi, M.; Andreassi, L., 2006:
Antioxidants in dermocosmetology: from the laboratory to clinical application

Hogl, O.; Wenger, F., 1954:
Antioxidants in fats and oils. I..

Wenger, F., 1954:
Antioxidants in fats and oils. II. Testing of oils and fats with Swift stability test

Wenger, F., 1954:
Antioxidants in fats and oils. III. Simple methods for detection of antioxidants

Hagymási, K.; Blázovics, A., 2004:
Antioxidants in liver protection

Nikiforova, N.V.; Berman, A.E., 2003:
Antioxidants in malignant neoplasms in humans and animals

Carlson, N.G.; Rose, J.W., 2006:
Antioxidants in multiple sclerosis: do they have a role in therapy?

Goldie, M.Perno., 2006:
Antioxidants in oral health care: making the connection

Gritz, D.C.; Srinivasan, M.; Smith, S.D.; Kim, U.; Lietman, T.M.; Wilkins, J.H.; Priyadharshini, B.; Aravind, S.; Prajna, N.Venkatesh.; Smolin, G.; Thulasiraj, R.Duraisami.; Selvaraj, S.; Whitcher, J.P., 2006:
Antioxidants in prevention of cataracts in South India: methodology and baseline data*

Choy, C.; Benzie, I.; Cho, P., 2003:
Antioxidants in tears and plasma: Inter-relationships and effect of vitamin C supplementation

Bogani, P.; Visioli, F., 2006:
Antioxidants in the Mediterranean diets: An update

Block, K.I., 2005:
Antioxidants in the news

Dal Brollo, F.; Polasek, G.; Rigamonti, S., 1956:
Antioxidants in the pharmaceutical field: their action on some vegetable oils. II

Novacic, L.; Polasek, G.; Rigamonti, S., 1955:
Antioxidants in the pharmaceutical field; their action on various fats

Luciak, M., 2005:
Antioxidants in the treatment of patients with renal failure

Joachims, H.Z.; Segal, J.; Golz, A.; Netzer, A.; Goldenberg, D., 2003:
Antioxidants in treatment of idiopathic sudden hearing loss

Tsiskarishvili, N.V.; Tsiskarishvili, T.I., 2006:
Antioxidants in vitiligo treatment

Muangman, P.; Tamura, R.N.; Gibran, N.S., 2005:
Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase gene expression in human microvascular endothelial cells

Medina, S.; Martínez, M.; Hernanz, A., 2003:
Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1-42

Siddiqui, I.A.; Afaq, F.; Adhami, V.M.; Ahmad, N.; Mukhtar, H., 2004:
Antioxidants of the beverage tea in promotion of human health

Dahan, A.; Romberg, R.; Sarton, E.; Teppema, L., 2004:
Antioxidants prevent blunting of hypoxic ventilatory response by low-dose halothane

Horáková, L.; Strosová, M.; Skuciová, Mária., 2006:
Antioxidants prevented oxidative injury of SR induced by Fe2+/H2O2/ascorbate system but failed to prevent Ca2+-ATPase activity decrease

Anonymous, 2006 :
Antioxidants reduce risk of macular degeneration

Karl-Heinz, W.; Haber, P.; Elmadfa, I., 2005:
Antioxidants status and physical fitness in seniors aerobically trained and supplemented with a multivitamin drink

Reliene, R.; Schiestl, R.H., 2006:
Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice

Phillips, M.; Curtis, H.; Portmann, B.; Donaldson, N.; Bomford, A.; O'Grady, J., 2006:
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial

Calò, L.A.; Bertipaglia, L.; Pagnin, E., 2006:
Antioxidants, carnitine and erythropoietin

Murtaugh, M.A.; Ma, K-ni.; Benson, J.; Curtin, K.; Caan, B.; Slattery, M.L., 2003:
Antioxidants, carotenoids, and risk of rectal cancer

Hlúbik, P.; Strítecká, H., 2004:
Antioxidants--clinical aspects

Biesalski, H.K., 2007:
Antioxidants--helpful or harmful?

Efremova, T.N.; Kirpichnikova, K.M.; Khaĭtlina, S.Iu.; Gamaleĭ, I.A., 2004:
Antioxidants-induced rearrangements of actin cytoskeleton in 3T3 and 3T3-SV40 fibroblasts

Anonymous, 2005:
Antioxidants. Protecting your cells from damage

Jacob, R.A., 2006:
Antioxidants. Should you supplement?

Barakat, M.Z.; Shehab, S.K.; Abdalla, A.M., 1960:
Antioxidants. The microdetermination of hydroquinone

Smith, E.M., 2005:
Antioxidants: a fountain of youth for the brain?

Binkley, J.F., 2005:
Antioxidants: bridging the gap between biochemistry and clinical practice

Pang, S-Qiu.; Wang, G-Quan.; Qin, L-Ping.; Huang, B-Kang.; Zhang, Q-Yan., 2006:
Antioxidation activities of Fructus Broussonetia haematochrome in vitro

Lu, P.; Lai, B-sen.; Liang, P.; Chen, Z-tong.; Shun, S-qing., 2004:
Antioxidation activity and protective effection of ginger oil on DNA damage in vitro

Liu, J-bo.; Tang, T-si.; Yang, H-lin., 2006:
Antioxidation of quercetin against spinal cord injury in rats

Augustyniak, A.; Skrzydlewska, E., 2004:
Antioxidative abilities during aging

Nagai, T.; Inoue, R.; Suzuki, N.; Myoda, T.; Nagashima, T., 2005:
Antioxidative ability in a linoleic acid oxidation system and scavenging abilities against active oxygen species of enzymatic hydrolysates from pollen Cistus ladaniferus

Pazourková, M.; Lojek, A.; Cíz, M.; Kubala, L.; Benes, L.; Farsa, O., 2003:
Antioxidative action of pyridoindoles and N-(alkoxyphenyl)-2-(2-oxo-1-aza-1-cycloalkyl) acetamides in biological, enzymatic and chemical systems

Watanabe, T.; Yasunari, K.; Nakamura, M., 2006 :
Antioxidative actions of statins: potential mechanisms for antiathersclerotic effects

Luo, J.; Yang, Y.; Lin, Y.; Chen, Z.; Jiang, G., 2004:
Antioxidative activities of two metabolites of cultured marine fungus, Halorosellinia oceanicum 323 in vitro

Kudoh, K.; Matsumoto, M.; Onodera, S.; Takeda, Y.; Ando, K.; Shiomi, N., 2004:
Antioxidative activity and protective effect against ethanol-induced gastric mucosal damage of a potato protein hydrolysate

Suzuki, N.; Fujimura, A.; Nagai, T.; Mizumoto, I.; Itami, T.; Hatate, H.; Nozawa, T.; Kato, N.; Nomoto, T.; Yoda, B., 2005:
Antioxidative activity of animal and vegetable dietary fibers

Suh, M-Hee.; Yoo, S-Ho.; Chang, P-Shick.; Lee, H.Gyu., 2005:
Antioxidative activity of microencapsulated gamma-oryzanol on high cholesterol-fed rats

Katalinić, V.; Radić, S.; Ropac, D.; Mulić, R.; Katalinić, A., 2005:
Antioxidative activity of propolis from Dalmatia (Croatia)

Muselík, J.; Hytych, P.; Zemlicka, M., 2005:
Antioxidative activity of some over-the-counter plant extracts

Nishimura, H.; Higuchi, O.; Tateshita, K., 2005:
Antioxidative activity of sulfur-containing compounds in Allium species for human LDL oxidation in vitro

Lei, X-yan.; Xu, A-xia.; Gao, X.; Ge, B., 2005:
Antioxidative activity of water-soluble extracts from Fructus Polygoni Orientalis

Kazazić, S.P., 2004:
Antioxidative and antiradical activity of flavonoids

Sroka, Z., 2006:
Antioxidative and antiradical properties of plant phenolics

Arakaki, J.; Suzui, M.; Morioka, T.; Kinjo, T.; Kaneshiro, T.; Inamine, M.; Sunagawa, N.; Nishimaki, T.; Yoshimi, N., 2006:
Antioxidative and modifying effects of a tropical plant Azadirachta indica (Neem) on azoxymethane-induced preneoplastic lesions in the rat colon

Weecharangsan, W.; Opanasopit, P.; Sukma, M.; Ngawhirunpat, T.; Sotanaphun, U.; Siripong, P., 2006:
Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.)

Schmidt, A.Johannes.; Krieg, Jürgen-Christian.; Vedder, H., 2005:
Antioxidative and steroid systems in neurological and psychiatric disorders

Modzelewski, B., 2005:
Antioxidative barrier activity assessment in gastro-esophageal reflux disease

Ly, T.Ngoc.; Shimoyamada, M.; Kato, K.; Yamauchi, R., 2005:
Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance)

Kratnov, A.E.; Popov, S.A.; Kratnov, A.A.; Dem'iankova, I.O., 2005:
Antioxidative defense in patients with acute coronary syndrome and concomitant type 2 diabetes and its modification by lisinopril

Barac, G., 1951:
Antioxidative effect of blood proteins on ascorbic acid and protein-vitamin C

Vogt, H., 1955:
Antioxidative effect of silicon oil in ointment bases. VI. Studies of drugs and galenic preparations

Lin, A.M.Y.; Chen, K.B.; Chao, P.L., 2005:
Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS